data_2hm4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hm4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.794 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.6 m . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.794 ' O ' ' O ' ' A' ' 8' ' ' CYS . 26.4 Cg_exo -24.06 171.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.045 3.164 . . . . 0.0 113.138 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.9 m -53.42 123.54 12.3 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.27 10.98 70.62 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.353 -1.403 . . . . 0.0 114.142 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.55 157.33 35.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.541 1.17 . . . . 0.0 110.769 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.674 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 2.1 t -71.79 141.67 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.384 0.611 . . . . 0.0 110.855 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -45.66 93.79 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.082 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.19 -8.89 42.73 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.44 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 87.7 m -82.07 -5.96 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 13.4 t80 -80.44 145.99 60.56 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.633 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.48 10.67 61.11 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.702 1.286 . . . . 0.0 112.364 -0.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.689 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 5.5 tt0 -63.81 -45.7 88.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.219 0.533 . . . . 0.0 109.994 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 74.3 m 43.87 44.43 1.46 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 95.2 Cg_endo -77.08 153.06 31.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.215 1.943 . . . . 0.0 109.887 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.56 -51.95 7.25 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 120.918 1.079 . . . . 0.0 112.565 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.61 -48.52 49.43 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.563 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.653 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 t -66.33 -27.61 68.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 110.417 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.0 m . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.3 m . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.775 ' O ' ' O ' ' A' ' 8' ' ' CYS . 31.2 Cg_exo -24.99 170.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.142 3.228 . . . . 0.0 112.959 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -53.7 123.31 11.91 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.522 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 11.35 71.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 118.952 -1.594 . . . . 0.0 114.15 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.635 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.4 t -73.89 157.16 36.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.628 1.214 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.772 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.7 m -71.86 118.58 14.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.43 -45.06 16.57 Favored Glycine 0 N--CA 1.46 0.271 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.405 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.19 -8.36 38.11 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.799 0.333 . . . . 0.0 110.863 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.772 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.2 m -83.09 -1.65 53.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 14.7 t80 -80.26 146.54 62.61 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -90.33 11.6 58.32 Favored 'Cis proline' 0 C--N 1.352 0.712 0 CA-C-N 120.665 1.273 . . . . 0.0 112.421 -0.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.703 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.4 tt0 -63.84 -45.48 89.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 109.983 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.7 m 43.36 42.86 0.88 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.703 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 96.2 Cg_endo -80.46 152.13 20.23 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.336 2.024 . . . . 0.0 110.305 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 -50.61 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 120.882 1.055 . . . . 0.0 112.172 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.65 -53.54 16.71 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.386 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.545 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.29 -26.39 67.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.31 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.621 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 61.9 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.897 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.7 m . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 119.566 -0.254 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 47.7 Cg_exo -24.04 170.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.188 3.259 . . . . 0.0 113.032 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -53.68 123.02 11.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 11.34 71.72 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.078 -1.534 . . . . 0.0 114.094 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.643 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -74.16 157.7 35.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.804 1.302 . . . . 0.0 111.224 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.752 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.0 m -71.98 119.63 16.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.735 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.14 -45.6 15.22 Favored Glycine 0 N--CA 1.461 0.322 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.286 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.31 -8.44 39.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 68.9 m -83.14 -4.39 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 18.9 t80 -80.34 146.44 62.03 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -89.81 10.48 61.43 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.537 1.228 . . . . 0.0 112.5 -0.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.573 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.7 tt0 -63.81 -45.87 87.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 73.1 m 43.82 42.54 0.88 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.628 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 96.5 Cg_endo -75.45 153.59 39.82 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.672 1.581 . . . . 0.0 109.977 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.59 -51.15 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 120.863 1.042 . . . . 0.0 112.132 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.42 -49.4 51.83 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.029 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.628 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 t -66.27 -27.64 68.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.191 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.4 m . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.447 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.772 ' O ' ' O ' ' A' ' 9' ' ' PRO . 24.1 m . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.772 ' O ' ' O ' ' A' ' 8' ' ' CYS . 48.6 Cg_exo -24.75 170.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 124.078 3.185 . . . . 0.0 112.975 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 m -53.67 123.83 13.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.333 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.29 70.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.291 -1.433 . . . . 0.0 114.124 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.665 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -73.91 159.55 32.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.886 1.343 . . . . 0.0 111.985 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.508 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 1.3 t -71.8 137.12 47.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.263 176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 -48.27 82.36 Favored Glycine 0 CA--C 1.502 -0.78 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.664 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.54 -9.4 42.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.346 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 88.7 m -82.0 -1.59 48.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.0 t80 -80.42 146.48 61.73 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.9 Cg_endo -90.08 12.21 56.78 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 120.65 1.268 . . . . 0.0 112.304 -0.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.625 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 3.2 tt0 -63.41 -46.02 88.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.596 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 72.3 m 43.89 43.27 1.06 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.646 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 89.2 Cg_endo -77.15 152.52 31.21 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.022 1.815 . . . . 0.0 110.217 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.01 -50.56 11.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 121.09 1.193 . . . . 0.0 112.501 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.55 -49.07 58.84 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.886 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.646 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.27 -27.12 67.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.887 0.375 . . . . 0.0 110.35 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 90.0 m . . . . . 0 N--CA 1.453 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.774 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.802 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.2 m . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.802 ' O ' ' O ' ' A' ' 8' ' ' CYS . 51.1 Cg_exo -22.43 170.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.286 3.324 . . . . 0.0 113.162 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -53.75 122.61 10.28 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 11.36 71.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 118.805 -1.664 . . . . 0.0 114.055 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.631 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.0 t -74.07 155.89 38.03 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.61 1.205 . . . . 0.0 110.628 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.75 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 36.5 m -71.94 124.42 24.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.883 0.373 . . . . 0.0 110.969 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.93 -45.92 41.05 Favored Glycine 0 N--CA 1.461 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -67.76 -8.1 32.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.729 0.3 . . . . 0.0 110.868 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 88.5 m -82.4 -1.89 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 11.3 t80 -80.22 146.27 62.16 Favored Pre-proline 0 N--CA 1.449 -0.507 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.31 11.06 60.2 Favored 'Cis proline' 0 C--N 1.354 0.824 0 CA-C-N 120.675 1.277 . . . . 0.0 112.096 -0.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.727 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 9.4 tt0 -63.8 -45.71 88.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.073 0.463 . . . . 0.0 110.12 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.1 m 43.5 45.58 1.91 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.727 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 98.0 Cg_endo -79.92 151.49 21.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.538 2.159 . . . . 0.0 110.335 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.06 -52.76 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.976 1.117 . . . . 0.0 112.405 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.29 -50.78 22.46 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.902 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.691 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.56 -28.18 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.008 0.433 . . . . 0.0 110.444 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 63.9 m . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.934 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' ' O ' ' A' ' 9' ' ' PRO . 30.1 m . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 119.406 -0.33 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.745 ' O ' ' O ' ' A' ' 8' ' ' CYS . 16.5 Cg_exo -26.62 170.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.112 3.208 . . . . 0.0 112.692 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 m -53.43 124.36 14.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.34 11.83 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.44 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 15.8 t -74.13 159.69 32.25 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 119.131 1.465 . . . . 0.0 111.79 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.705 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.5 m -71.65 119.34 15.67 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.198 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.82 -46.83 31.56 Favored Glycine 0 N--CA 1.463 0.44 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.73 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.69 -8.72 37.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 110.726 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -83.05 -1.95 54.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 t80 -80.69 147.74 63.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.218 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 13.1 Cg_endo -90.92 14.3 50.97 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 120.396 1.177 . . . . 0.0 112.073 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.692 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 1.5 tt0 -63.72 -47.06 82.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.012 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 78.9 m 45.32 42.65 1.05 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HD3' ' CG ' ' A' ' 19' ' ' GLU . 97.2 Cg_endo -75.78 151.47 36.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.714 1.609 . . . . 0.0 109.096 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -49.45 14.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 120.89 1.06 . . . . 0.0 112.184 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.15 -50.1 47.31 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.981 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.623 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.4 t -66.13 -27.2 67.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 0.0 110.553 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.588 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.2 m . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 54.1 m . . . . . 0 N--CA 1.439 -0.976 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 52.6 Cg_exo -25.14 170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.667 2.911 . . . . 0.0 113.118 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 m -53.67 122.99 10.99 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.628 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.57 72.74 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.229 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.597 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.3 t -73.88 157.78 35.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.769 1.284 . . . . 0.0 111.536 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.496 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 20.1 m -70.96 132.33 45.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.777 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.94 93.17 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.888 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.15 -8.26 22.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.855 0.36 . . . . 0.0 110.581 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 56.8 m -82.01 -13.1 57.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 25.4 t80 -78.89 145.46 66.13 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.674 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -88.99 7.63 67.91 Favored 'Cis proline' 0 C--N 1.356 0.972 0 CA-C-N 120.041 1.05 . . . . 0.0 112.858 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 42.2 tt0 -64.33 -43.38 94.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 111.098 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.542 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 84.2 m 47.39 40.92 0.78 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 39.7 Cg_exo -58.05 150.97 61.4 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.293 1.329 . . . . 0.0 110.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.4 -56.67 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 120.941 1.094 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -27.83 69.41 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.674 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 5.9 t -66.32 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.184 0.516 . . . . 0.0 109.895 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 71.0 m . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.737 ' O ' ' O ' ' A' ' 9' ' ' PRO . 62.1 m . . . . . 0 N--CA 1.438 -1.074 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.737 ' O ' ' O ' ' A' ' 8' ' ' CYS . 17.3 Cg_exo -28.45 170.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.286 2.657 . . . . 0.0 112.812 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.3 m -53.46 124.86 16.04 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.63 72.78 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.272 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -73.89 159.46 32.78 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.145 1.472 . . . . 0.0 111.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.692 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 71.6 m -71.32 123.61 22.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.525 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.97 -46.32 55.61 Favored Glycine 0 N--CA 1.461 0.357 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.294 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.23 -8.05 28.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.652 0.263 . . . . 0.0 110.856 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 64.4 m -82.22 -3.4 55.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 13.5 t80 -80.74 146.24 59.84 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.62 10.42 61.69 Favored 'Cis proline' 0 C--N 1.351 0.66 0 CA-C-N 120.806 1.324 . . . . 0.0 112.419 -0.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.643 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 tp10 -63.78 -45.42 89.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 86.9 m 43.73 43.98 1.28 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 90.0 Cg_endo -78.04 154.34 29.28 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.027 1.818 . . . . 0.0 110.347 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.73 -52.71 5.59 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.064 1.176 . . . . 0.0 112.802 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.03 -43.6 72.67 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.044 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.714 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.58 -26.47 67.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.559 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 66.9 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.778 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.7 m . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.778 ' O ' ' O ' ' A' ' 8' ' ' CYS . 22.6 Cg_exo -26.2 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.762 2.975 . . . . 0.0 112.561 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.0 m -53.54 125.25 17.41 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.3 11.23 71.08 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 118.962 -1.589 . . . . 0.0 114.319 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 12.3 t -74.39 159.41 32.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.926 1.363 . . . . 0.0 111.404 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.69 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.7 m -71.61 118.56 14.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.549 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -47.67 -46.86 24.38 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.97 -8.66 39.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.673 0.273 . . . . 0.0 110.858 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -82.91 -1.8 53.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 14.0 t80 -80.95 147.04 60.67 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.862 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 12.5 Cg_endo -90.68 13.38 53.6 Favored 'Cis proline' 0 C--N 1.351 0.693 0 CA-C-N 120.517 1.22 . . . . 0.0 112.191 -1.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.714 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 18.2 tt0 -63.89 -47.01 82.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 109.881 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.503 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 75.9 m 44.07 44.42 1.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 73.6 Cg_endo -75.42 152.58 39.0 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 109.035 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.75 -49.94 13.13 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.854 1.036 . . . . 0.0 112.5 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.07 -46.25 78.72 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.482 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.692 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.2 t -66.37 -25.96 67.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 85.7 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' O ' ' O ' ' A' ' 9' ' ' PRO . 55.2 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.78 ' O ' ' O ' ' A' ' 8' ' ' CYS . 32.4 Cg_exo -25.55 170.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.873 3.048 . . . . 0.0 112.899 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.48 123.1 11.14 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.6 11.65 72.92 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.265 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.618 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.9 t -74.15 159.15 32.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.108 1.454 . . . . 0.0 111.481 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.694 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 53.2 m -71.12 121.92 19.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.183 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.91 -47.04 40.46 Favored Glycine 0 N--CA 1.461 0.348 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.57 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -8.11 27.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 72.3 m -81.98 -2.23 50.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 15.2 t80 -80.6 146.58 61.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.59 10.65 61.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 120.537 1.227 . . . . 0.0 112.328 -0.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.74 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 28.2 tt0 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.048 0.451 . . . . 0.0 110.025 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 76.3 m 45.47 43.58 1.39 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.74 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 91.4 Cg_endo -75.94 153.66 37.6 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.29 1.993 . . . . 0.0 110.078 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.6 -52.62 5.87 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.908 1.072 . . . . 0.0 112.536 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.66 -45.54 60.02 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.77 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.72 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.6 t -66.51 -29.19 69.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 109.833 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.9 m . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.065 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.18 155.04 17.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 110.808 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -138.08 146.66 43.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.616 ' O ' ' HE2' ' A' ' 17' ' ' TYR . 2.0 pp -142.07 -38.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.071 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 149.07 49.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 111.449 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.558 ' N ' ' CE2' ' A' ' 17' ' ' TYR . . . 174.83 -172.62 45.62 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.45 139.95 35.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.884 0.85 . . . . 0.0 111.656 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.794 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.6 m -81.86 162.18 58.38 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.475 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.794 ' O ' ' O ' ' A' ' 8' ' ' CYS . 26.4 Cg_exo -24.06 171.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.045 3.164 . . . . 0.0 113.138 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.9 m -53.42 123.54 12.3 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.27 10.98 70.62 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.353 -1.403 . . . . 0.0 114.142 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.55 157.33 35.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.541 1.17 . . . . 0.0 110.769 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.674 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 2.1 t -71.79 141.67 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.384 0.611 . . . . 0.0 110.855 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -45.66 93.79 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.082 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.19 -8.89 42.73 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.44 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 87.7 m -82.07 -5.96 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.616 ' HE2' ' O ' ' A' ' 4' ' ' ILE . 13.4 t80 -80.44 145.99 60.56 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.633 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.48 10.67 61.11 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.702 1.286 . . . . 0.0 112.364 -0.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.689 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 5.5 tt0 -63.81 -45.7 88.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.219 0.533 . . . . 0.0 109.994 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 74.3 m 43.87 44.43 1.46 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 95.2 Cg_endo -77.08 153.06 31.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.215 1.943 . . . . 0.0 109.887 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.56 -51.95 7.25 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 120.918 1.079 . . . . 0.0 112.565 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.61 -48.52 49.43 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.563 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.653 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 t -66.33 -27.61 68.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 110.417 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.0 m -74.79 -43.34 55.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.344 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.92 -34.64 11.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.736 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.53 ' C ' HG23 ' A' ' 28' ' ' VAL . 41.9 mt-30 -113.88 139.93 48.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.742 0.306 . . . . 0.0 111.026 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG23 ' C ' ' A' ' 27' ' ' GLN . 14.2 t -145.33 118.4 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.0 94.82 1.03 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.884 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.558 HD13 ' OXT' ' A' ' 31' ' ' ASN . 2.2 pp -67.44 -13.27 61.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.499 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.558 ' OXT' HD13 ' A' ' 30' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.38 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.38 160.43 39.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.739 0.304 . . . . 0.0 110.548 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.4 144.58 49.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.28 151.71 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -131.65 -179.98 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 17' ' ' TYR . . . 176.3 -174.64 47.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.126 -1.035 . . . . 0.0 115.604 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 141.02 32.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.934 0.873 . . . . 0.0 111.291 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.3 m -82.11 162.12 57.96 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.486 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.775 ' O ' ' O ' ' A' ' 8' ' ' CYS . 31.2 Cg_exo -24.99 170.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.142 3.228 . . . . 0.0 112.959 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -53.7 123.31 11.91 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.522 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 11.35 71.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 118.952 -1.594 . . . . 0.0 114.15 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.635 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.4 t -73.89 157.16 36.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.628 1.214 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.772 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.7 m -71.86 118.58 14.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.43 -45.06 16.57 Favored Glycine 0 N--CA 1.46 0.271 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.405 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.19 -8.36 38.11 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.799 0.333 . . . . 0.0 110.863 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.772 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.2 m -83.09 -1.65 53.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CE2' ' N ' ' A' ' 6' ' ' GLY . 14.7 t80 -80.26 146.54 62.61 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -90.33 11.6 58.32 Favored 'Cis proline' 0 C--N 1.352 0.712 0 CA-C-N 120.665 1.273 . . . . 0.0 112.421 -0.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.703 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.4 tt0 -63.84 -45.48 89.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 109.983 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.7 m 43.36 42.86 0.88 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.703 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 96.2 Cg_endo -80.46 152.13 20.23 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.336 2.024 . . . . 0.0 110.305 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 -50.61 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 120.882 1.055 . . . . 0.0 112.172 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.65 -53.54 16.71 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.386 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.545 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.29 -26.39 67.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.31 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.621 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 61.9 m -75.06 -41.87 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.897 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -41.43 -70.8 0.39 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.545 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.569 ' HG3' ' HG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER 51.55 116.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.8 t 63.68 132.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.085 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -150.66 131.42 14.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HA ' HD11 ' A' ' 30' ' ' LEU . 3.4 mm? -109.54 67.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.6 p30 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.836 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.06 154.34 17.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.651 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 147.6 47.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.036 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.466 HD12 HG23 ' A' ' 5' ' ' THR . 2.4 pp -113.68 -41.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.548 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.466 HG23 HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -93.44 114.47 26.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.485 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.522 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 175.56 176.21 43.62 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.325 -0.94 . . . . 0.0 114.924 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.4 140.23 34.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.868 0.842 . . . . 0.0 111.441 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.7 m -82.22 161.99 58.1 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.948 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 47.7 Cg_exo -24.04 170.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.188 3.259 . . . . 0.0 113.032 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -53.68 123.02 11.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 11.34 71.72 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.078 -1.534 . . . . 0.0 114.094 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.643 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -74.16 157.7 35.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.804 1.302 . . . . 0.0 111.224 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.752 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.0 m -71.98 119.63 16.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.735 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.14 -45.6 15.22 Favored Glycine 0 N--CA 1.461 0.322 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.286 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.31 -8.44 39.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 68.9 m -83.14 -4.39 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 18.9 t80 -80.34 146.44 62.03 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -89.81 10.48 61.43 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.537 1.228 . . . . 0.0 112.5 -0.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.573 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.7 tt0 -63.81 -45.87 87.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 73.1 m 43.82 42.54 0.88 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.628 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 96.5 Cg_endo -75.45 153.59 39.82 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.672 1.581 . . . . 0.0 109.977 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.59 -51.15 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 120.863 1.042 . . . . 0.0 112.132 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.42 -49.4 51.83 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.029 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.628 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 t -66.27 -27.64 68.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.191 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.4 m -74.73 -42.52 58.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.447 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -41.06 -29.63 0.33 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.575 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.519 ' HG2' ' OG ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 54.42 158.69 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 111.697 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG21 ' C ' ' A' ' 27' ' ' GLN . 14.7 t -144.26 120.35 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -56.7 94.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.954 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 tp -96.79 -74.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.985 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.931 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -138.3 146.41 42.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 111.07 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -144.84 148.56 34.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.574 HD12 HG22 ' A' ' 5' ' ' THR . 1.6 pp -126.28 -43.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.196 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.574 HG22 HD12 ' A' ' 4' ' ' ILE . 5.0 t -173.19 -177.91 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.261 . . . . 0.0 110.91 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA2' ' CZ ' ' A' ' 17' ' ' TYR . . . -160.87 52.06 0.34 Allowed Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 119.232 -1.461 . . . . 0.0 114.857 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 132.27 27.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.248 -0.976 . . . . 0.0 110.256 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.772 ' O ' ' O ' ' A' ' 9' ' ' PRO . 24.1 m -81.93 162.19 58.17 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.219 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.772 ' O ' ' O ' ' A' ' 8' ' ' CYS . 48.6 Cg_exo -24.75 170.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 124.078 3.185 . . . . 0.0 112.975 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 m -53.67 123.83 13.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.333 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.29 70.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.291 -1.433 . . . . 0.0 114.124 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.665 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -73.91 159.55 32.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.886 1.343 . . . . 0.0 111.985 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.508 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 1.3 t -71.8 137.12 47.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.263 176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 -48.27 82.36 Favored Glycine 0 CA--C 1.502 -0.78 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.664 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.54 -9.4 42.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.346 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 88.7 m -82.0 -1.59 48.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' CZ ' ' HA2' ' A' ' 6' ' ' GLY . 21.0 t80 -80.42 146.48 61.73 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.9 Cg_endo -90.08 12.21 56.78 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 120.65 1.268 . . . . 0.0 112.304 -0.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.625 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 3.2 tt0 -63.41 -46.02 88.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.596 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 72.3 m 43.89 43.27 1.06 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.646 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 89.2 Cg_endo -77.15 152.52 31.21 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.022 1.815 . . . . 0.0 110.217 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.01 -50.56 11.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 121.09 1.193 . . . . 0.0 112.501 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.55 -49.07 58.84 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.886 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.646 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.27 -27.12 67.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.887 0.375 . . . . 0.0 110.35 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 90.0 m -74.17 -44.79 52.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.774 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.36 -44.43 95.18 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.58 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 28' ' ' VAL . 3.0 pt20 40.38 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.039 0.447 . . . . 0.0 112.146 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 27' ' ' GLN . 2.5 p 40.67 114.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.77 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -119.57 137.36 53.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.6 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -20.76 65.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 t -159.44 158.99 33.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.1 148.44 45.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.73 HD12 HG23 ' A' ' 5' ' ' THR . 2.6 pp -75.56 -41.35 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.547 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.73 HG23 HD12 ' A' ' 4' ' ' ILE . 13.1 t -133.34 163.73 28.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.311 0.577 . . . . 0.0 111.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.538 ' N ' ' CE1' ' A' ' 17' ' ' TYR . . . 173.01 -167.41 40.21 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.66 139.1 35.82 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.959 0.885 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.802 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.2 m -81.78 162.07 58.96 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.754 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.802 ' O ' ' O ' ' A' ' 8' ' ' CYS . 51.1 Cg_exo -22.43 170.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.286 3.324 . . . . 0.0 113.162 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -53.75 122.61 10.28 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 11.36 71.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 118.805 -1.664 . . . . 0.0 114.055 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.631 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.0 t -74.07 155.89 38.03 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.61 1.205 . . . . 0.0 110.628 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.75 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 36.5 m -71.94 124.42 24.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.883 0.373 . . . . 0.0 110.969 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.93 -45.92 41.05 Favored Glycine 0 N--CA 1.461 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -67.76 -8.1 32.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.729 0.3 . . . . 0.0 110.868 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 88.5 m -82.4 -1.89 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CE1' ' HA ' ' A' ' 5' ' ' THR . 11.3 t80 -80.22 146.27 62.16 Favored Pre-proline 0 N--CA 1.449 -0.507 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.31 11.06 60.2 Favored 'Cis proline' 0 C--N 1.354 0.824 0 CA-C-N 120.675 1.277 . . . . 0.0 112.096 -0.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.727 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 9.4 tt0 -63.8 -45.71 88.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.073 0.463 . . . . 0.0 110.12 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.54 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.1 m 43.5 45.58 1.91 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.727 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 98.0 Cg_endo -79.92 151.49 21.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.538 2.159 . . . . 0.0 110.335 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.06 -52.76 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.976 1.117 . . . . 0.0 112.405 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.29 -50.78 22.46 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.902 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.691 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.56 -28.18 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.008 0.433 . . . . 0.0 110.444 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 63.9 m -74.85 -40.9 60.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.934 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -41.25 -23.96 0.1 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.659 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.502 ' C ' HG21 ' A' ' 28' ' ' VAL . 6.2 mm-40 -66.17 107.76 2.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.986 0.393 . . . . 0.0 111.43 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG21 ' C ' ' A' ' 27' ' ' GLN . 7.7 t -145.88 118.48 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.389 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.8 119.53 31.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.539 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.03 51.7 0.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 111.206 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.913 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -176.6 164.14 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 110.962 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 59.84 151.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.712 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pp -114.32 152.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.993 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.613 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 3.4 t -112.15 -177.39 3.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.54 0.685 . . . . 0.0 112.031 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' N ' ' CZ ' ' A' ' 17' ' ' TYR . . . 73.02 -5.47 18.37 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 115.931 1.132 . . . . 0.0 115.931 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.72 130.28 29.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.335 1.064 . . . . 0.0 112.599 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' ' O ' ' A' ' 9' ' ' PRO . 30.1 m -82.51 162.82 54.68 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.2 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.745 ' O ' ' O ' ' A' ' 8' ' ' CYS . 16.5 Cg_exo -26.62 170.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.112 3.208 . . . . 0.0 112.692 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 m -53.43 124.36 14.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.34 11.83 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.44 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 15.8 t -74.13 159.69 32.25 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 119.131 1.465 . . . . 0.0 111.79 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.705 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.5 m -71.65 119.34 15.67 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.198 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.82 -46.83 31.56 Favored Glycine 0 N--CA 1.463 0.44 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.73 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.69 -8.72 37.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 110.726 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -83.05 -1.95 54.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' OH ' ' HA ' ' A' ' 5' ' ' THR . 16.1 t80 -80.69 147.74 63.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.218 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 13.1 Cg_endo -90.92 14.3 50.97 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 120.396 1.177 . . . . 0.0 112.073 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.692 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 1.5 tt0 -63.72 -47.06 82.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.012 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 78.9 m 45.32 42.65 1.05 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HD3' ' CG ' ' A' ' 19' ' ' GLU . 97.2 Cg_endo -75.78 151.47 36.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.714 1.609 . . . . 0.0 109.096 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -49.45 14.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 120.89 1.06 . . . . 0.0 112.184 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.15 -50.1 47.31 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.981 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.623 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.4 t -66.13 -27.2 67.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 0.0 110.553 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.588 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.2 m -74.62 -44.32 51.12 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.16 -44.75 90.46 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.853 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.43 ' C ' HG21 ' A' ' 28' ' ' VAL . 9.6 mm-40 -80.42 137.75 36.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.473 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG21 ' C ' ' A' ' 27' ' ' GLN . 3.0 t -147.5 116.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.681 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.29 116.09 15.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 62.62 1.64 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.939 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -171.65 120.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.611 0.243 . . . . 0.0 110.811 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.36 153.75 5.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.126 0.489 . . . . 0.0 111.897 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.502 ' O ' HG22 ' A' ' 5' ' ' THR . 2.6 pp -144.9 -31.68 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.152 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 4' ' ' ILE . 6.8 t 50.47 160.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.049 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.698 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 72.58 144.04 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.081 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 144.82 36.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.958 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 54.1 m -81.8 161.81 59.78 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.728 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 52.6 Cg_exo -25.14 170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.667 2.911 . . . . 0.0 113.118 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 m -53.67 122.99 10.99 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.628 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.57 72.74 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.229 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.597 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.3 t -73.88 157.78 35.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.769 1.284 . . . . 0.0 111.536 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.496 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 20.1 m -70.96 132.33 45.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.777 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.94 93.17 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.888 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.15 -8.26 22.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.855 0.36 . . . . 0.0 110.581 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 56.8 m -82.01 -13.1 57.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.698 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 25.4 t80 -78.89 145.46 66.13 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.674 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -88.99 7.63 67.91 Favored 'Cis proline' 0 C--N 1.356 0.972 0 CA-C-N 120.041 1.05 . . . . 0.0 112.858 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.61 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 42.2 tt0 -64.33 -43.38 94.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 111.098 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.542 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 84.2 m 47.39 40.92 0.78 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.61 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 39.7 Cg_exo -58.05 150.97 61.4 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.293 1.329 . . . . 0.0 110.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.4 -56.67 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 120.941 1.094 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -27.83 69.41 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.674 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.518 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 5.9 t -66.32 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.184 0.516 . . . . 0.0 109.895 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.51 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 71.0 m -74.6 -43.74 54.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.78 -55.02 8.71 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.482 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -87.66 140.03 29.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.04 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.418 HG23 ' OG ' ' A' ' 13' ' ' SER . 3.5 t -143.49 113.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.645 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.479 ' C ' ' H ' ' A' ' 31' ' ' ASN . 5.4 t-20 -127.23 73.54 1.44 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.564 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pp -75.48 25.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 29' ' ' ASN . 3.8 m-80 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.727 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.922 -0.071 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.496 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 72.4 m -151.28 94.9 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.994 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 2' ' ' SER . 13.1 mt-30 -151.71 147.96 27.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.644 HD11 ' O ' ' A' ' 5' ' ' THR . 2.2 pp -80.4 140.46 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.644 ' O ' HD11 ' A' ' 4' ' ' ILE . 12.1 t -62.07 160.85 11.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.682 0.753 . . . . 0.0 111.291 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.607 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 71.08 136.1 0.14 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.833 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 142.57 35.01 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 109.643 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.737 ' O ' ' O ' ' A' ' 9' ' ' PRO . 62.1 m -81.69 161.77 60.22 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.522 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.737 ' O ' ' O ' ' A' ' 8' ' ' CYS . 17.3 Cg_exo -28.45 170.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.286 2.657 . . . . 0.0 112.812 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.3 m -53.46 124.86 16.04 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.63 72.78 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.272 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -73.89 159.46 32.78 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.145 1.472 . . . . 0.0 111.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.692 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 71.6 m -71.32 123.61 22.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.525 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.97 -46.32 55.61 Favored Glycine 0 N--CA 1.461 0.357 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.294 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.23 -8.05 28.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.652 0.263 . . . . 0.0 110.856 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 64.4 m -82.22 -3.4 55.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.607 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 13.5 t80 -80.74 146.24 59.84 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.62 10.42 61.69 Favored 'Cis proline' 0 C--N 1.351 0.66 0 CA-C-N 120.806 1.324 . . . . 0.0 112.419 -0.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.643 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 tp10 -63.78 -45.42 89.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 86.9 m 43.73 43.98 1.28 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 90.0 Cg_endo -78.04 154.34 29.28 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.027 1.818 . . . . 0.0 110.347 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.73 -52.71 5.59 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.064 1.176 . . . . 0.0 112.802 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.03 -43.6 72.67 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.044 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.714 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.58 -26.47 67.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.559 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 66.9 m -74.39 -43.71 55.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.95 -64.06 4.27 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.753 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 41.18 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 28' ' ' VAL . 7.4 p -170.49 131.02 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.274 0.559 . . . . 0.0 111.361 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.58 144.38 47.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.012 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 0.77 26.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.004 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.741 -179.544 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -137.98 95.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.04 154.85 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.505 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.89 150.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.499 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 3.4 t -100.47 -176.96 3.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.373 0.606 . . . . 0.0 111.566 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.49 ' N ' ' CZ ' ' A' ' 17' ' ' TYR . . . 72.1 -2.4 27.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.31 130.2 28.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.189 0.995 . . . . 0.0 112.874 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.778 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.7 m -82.58 162.13 56.77 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.765 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.778 ' O ' ' O ' ' A' ' 8' ' ' CYS . 22.6 Cg_exo -26.2 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.762 2.975 . . . . 0.0 112.561 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.0 m -53.54 125.25 17.41 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.3 11.23 71.08 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 118.962 -1.589 . . . . 0.0 114.319 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 12.3 t -74.39 159.41 32.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.926 1.363 . . . . 0.0 111.404 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.69 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.7 m -71.61 118.56 14.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.549 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -47.67 -46.86 24.38 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.97 -8.66 39.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.673 0.273 . . . . 0.0 110.858 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -82.91 -1.8 53.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' OH ' ' HA ' ' A' ' 5' ' ' THR . 14.0 t80 -80.95 147.04 60.67 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.862 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 12.5 Cg_endo -90.68 13.38 53.6 Favored 'Cis proline' 0 C--N 1.351 0.693 0 CA-C-N 120.517 1.22 . . . . 0.0 112.191 -1.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.714 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 18.2 tt0 -63.89 -47.01 82.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 109.881 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.503 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 75.9 m 44.07 44.42 1.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.714 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 73.6 Cg_endo -75.42 152.58 39.0 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 109.035 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.75 -49.94 13.13 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.854 1.036 . . . . 0.0 112.5 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.07 -46.25 78.72 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.482 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.692 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.2 t -66.37 -25.96 67.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 85.7 m -74.63 -44.88 48.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.603 ' O ' HG22 ' A' ' 28' ' ' VAL . . . -87.28 -46.66 4.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.75 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 13.7 pt20 43.2 72.24 0.19 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.169 0.509 . . . . 0.0 111.903 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 26' ' ' GLY . 11.4 t -154.8 120.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.605 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.52 100.86 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.993 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 30' ' ' LEU . 2.4 tt -91.76 -66.77 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.181 -179.49 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.625 -0.19 . . . . 0.0 112.625 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.23 115.43 23.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.495 0.188 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 60.37 150.95 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.548 HD13 HG23 ' A' ' 5' ' ' THR . 1.6 pp -121.15 -49.13 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.502 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.548 HG23 HD13 ' A' ' 4' ' ' ILE . 6.8 t -165.94 -175.51 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.624 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.556 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 74.05 146.6 1.07 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 114.809 0.684 . . . . 0.0 114.809 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.79 142.63 34.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' O ' ' O ' ' A' ' 9' ' ' PRO . 55.2 m -81.91 161.91 59.17 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.668 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.78 ' O ' ' O ' ' A' ' 8' ' ' CYS . 32.4 Cg_exo -25.55 170.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.873 3.048 . . . . 0.0 112.899 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.48 123.1 11.14 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.6 11.65 72.92 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.265 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.618 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.9 t -74.15 159.15 32.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.108 1.454 . . . . 0.0 111.481 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.694 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 53.2 m -71.12 121.92 19.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.183 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.91 -47.04 40.46 Favored Glycine 0 N--CA 1.461 0.348 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.57 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -8.11 27.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.694 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 72.3 m -81.98 -2.23 50.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.556 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 15.2 t80 -80.6 146.58 61.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.445 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.59 10.65 61.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 120.537 1.227 . . . . 0.0 112.328 -0.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.74 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 28.2 tt0 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.048 0.451 . . . . 0.0 110.025 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 76.3 m 45.47 43.58 1.39 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.74 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 91.4 Cg_endo -75.94 153.66 37.6 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.29 1.993 . . . . 0.0 110.078 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.6 -52.62 5.87 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.908 1.072 . . . . 0.0 112.536 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.66 -45.54 60.02 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.77 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 4.6 t -66.51 -29.19 69.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 109.833 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.9 m -75.11 -43.42 52.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.065 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.651 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.45 -53.7 5.84 Favored Glycine 0 CA--C 1.517 0.186 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.036 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.7 pp0? 38.03 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.944 0.402 . . . . 0.0 111.903 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 27' ' ' GLN . 91.5 t 66.1 124.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.316 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.4 143.72 32.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.315 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -63.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.07 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.065 -179.765 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.794 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.6 m . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.794 ' O ' ' O ' ' A' ' 8' ' ' CYS . 26.4 Cg_exo -24.06 171.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.045 3.164 . . . . 0.0 113.138 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.9 m -53.42 123.54 12.3 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.27 10.98 70.62 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.353 -1.403 . . . . 0.0 114.142 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.55 157.33 35.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.541 1.17 . . . . 0.0 110.769 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.68 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 2.1 t -71.79 141.67 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.384 0.611 . . . . 0.0 110.855 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -45.66 93.79 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.082 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.19 -8.89 42.73 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.44 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 87.7 m -82.07 -5.96 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 13.4 t80 -80.44 145.99 60.56 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.633 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.48 10.67 61.11 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.702 1.286 . . . . 0.0 112.364 -0.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 5.5 tt0 -63.81 -45.7 88.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.219 0.533 . . . . 0.0 109.994 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 74.3 m 43.87 44.43 1.46 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 95.2 Cg_endo -77.08 153.06 31.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.215 1.943 . . . . 0.0 109.887 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.56 -51.95 7.25 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 120.918 1.079 . . . . 0.0 112.565 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.61 -48.52 49.43 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.563 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.682 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 t -66.33 -27.61 68.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 110.417 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.0 m . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.3 m . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.775 ' O ' ' O ' ' A' ' 8' ' ' CYS . 31.2 Cg_exo -24.99 170.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.142 3.228 . . . . 0.0 112.959 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -53.7 123.31 11.91 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.522 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 11.35 71.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 118.952 -1.594 . . . . 0.0 114.15 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.4 t -73.89 157.16 36.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.628 1.214 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.799 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.7 m -71.86 118.58 14.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.43 -45.06 16.57 Favored Glycine 0 N--CA 1.46 0.271 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.405 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.19 -8.36 38.11 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.799 0.333 . . . . 0.0 110.863 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.2 m -83.09 -1.65 53.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 14.7 t80 -80.26 146.54 62.61 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -90.33 11.6 58.32 Favored 'Cis proline' 0 C--N 1.352 0.712 0 CA-C-N 120.665 1.273 . . . . 0.0 112.421 -0.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.688 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.4 tt0 -63.84 -45.48 89.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 109.983 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.7 m 43.36 42.86 0.88 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 96.2 Cg_endo -80.46 152.13 20.23 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.336 2.024 . . . . 0.0 110.305 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 -50.61 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 120.882 1.055 . . . . 0.0 112.172 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.65 -53.54 16.71 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.386 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.572 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.29 -26.39 67.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.31 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.629 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 61.9 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.897 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.7 m . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 119.566 -0.254 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 47.7 Cg_exo -24.04 170.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.188 3.259 . . . . 0.0 113.032 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -53.68 123.02 11.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 11.34 71.72 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.078 -1.534 . . . . 0.0 114.094 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -74.16 157.7 35.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.804 1.302 . . . . 0.0 111.224 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.778 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.0 m -71.98 119.63 16.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.735 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.14 -45.6 15.22 Favored Glycine 0 N--CA 1.461 0.322 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.286 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.31 -8.44 39.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 68.9 m -83.14 -4.39 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 18.9 t80 -80.34 146.44 62.03 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -89.81 10.48 61.43 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.537 1.228 . . . . 0.0 112.5 -0.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.7 tt0 -63.81 -45.87 87.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 73.1 m 43.82 42.54 0.88 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 96.5 Cg_endo -75.45 153.59 39.82 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.672 1.581 . . . . 0.0 109.977 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.59 -51.15 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 120.863 1.042 . . . . 0.0 112.132 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.42 -49.4 51.83 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.029 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.5 t -66.27 -27.64 68.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.191 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.4 m . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.447 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.772 ' O ' ' O ' ' A' ' 9' ' ' PRO . 24.1 m . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.772 ' O ' ' O ' ' A' ' 8' ' ' CYS . 48.6 Cg_exo -24.75 170.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 124.078 3.185 . . . . 0.0 112.975 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 m -53.67 123.83 13.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.333 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.29 70.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.291 -1.433 . . . . 0.0 114.124 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.671 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -73.91 159.55 32.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.886 1.343 . . . . 0.0 111.985 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 1.3 t -71.8 137.12 47.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.263 176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 -48.27 82.36 Favored Glycine 0 CA--C 1.502 -0.78 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.664 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.54 -9.4 42.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.346 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 88.7 m -82.0 -1.59 48.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.0 t80 -80.42 146.48 61.73 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.9 Cg_endo -90.08 12.21 56.78 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 120.65 1.268 . . . . 0.0 112.304 -0.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 3.2 tt0 -63.41 -46.02 88.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 72.3 m 43.89 43.27 1.06 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 89.2 Cg_endo -77.15 152.52 31.21 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.022 1.815 . . . . 0.0 110.217 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.01 -50.56 11.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 121.09 1.193 . . . . 0.0 112.501 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.55 -49.07 58.84 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.886 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.705 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.27 -27.12 67.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.887 0.375 . . . . 0.0 110.35 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 90.0 m . . . . . 0 N--CA 1.453 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.774 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.802 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.2 m . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.802 ' O ' ' O ' ' A' ' 8' ' ' CYS . 51.1 Cg_exo -22.43 170.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.286 3.324 . . . . 0.0 113.162 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -53.75 122.61 10.28 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 11.36 71.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 118.805 -1.664 . . . . 0.0 114.055 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.0 t -74.07 155.89 38.03 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.61 1.205 . . . . 0.0 110.628 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.784 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 36.5 m -71.94 124.42 24.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.883 0.373 . . . . 0.0 110.969 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.93 -45.92 41.05 Favored Glycine 0 N--CA 1.461 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -67.76 -8.1 32.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.729 0.3 . . . . 0.0 110.868 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 88.5 m -82.4 -1.89 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 11.3 t80 -80.22 146.27 62.16 Favored Pre-proline 0 N--CA 1.449 -0.507 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.31 11.06 60.2 Favored 'Cis proline' 0 C--N 1.354 0.824 0 CA-C-N 120.675 1.277 . . . . 0.0 112.096 -0.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.731 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 9.4 tt0 -63.8 -45.71 88.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.073 0.463 . . . . 0.0 110.12 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.1 m 43.5 45.58 1.91 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 98.0 Cg_endo -79.92 151.49 21.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.538 2.159 . . . . 0.0 110.335 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.06 -52.76 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.976 1.117 . . . . 0.0 112.405 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.29 -50.78 22.46 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.902 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.727 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.56 -28.18 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.008 0.433 . . . . 0.0 110.444 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 63.9 m . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.934 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' ' O ' ' A' ' 9' ' ' PRO . 30.1 m . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 119.406 -0.33 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.745 ' O ' ' O ' ' A' ' 8' ' ' CYS . 16.5 Cg_exo -26.62 170.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.112 3.208 . . . . 0.0 112.692 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 m -53.43 124.36 14.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.34 11.83 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.44 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.641 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 15.8 t -74.13 159.69 32.25 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 119.131 1.465 . . . . 0.0 111.79 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.737 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.5 m -71.65 119.34 15.67 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.198 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.82 -46.83 31.56 Favored Glycine 0 N--CA 1.463 0.44 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.73 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.69 -8.72 37.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 110.726 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -83.05 -1.95 54.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 t80 -80.69 147.74 63.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.218 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 13.1 Cg_endo -90.92 14.3 50.97 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 120.396 1.177 . . . . 0.0 112.073 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.698 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 1.5 tt0 -63.72 -47.06 82.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.012 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 78.9 m 45.32 42.65 1.05 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' CG ' ' A' ' 19' ' ' GLU . 97.2 Cg_endo -75.78 151.47 36.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.714 1.609 . . . . 0.0 109.096 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -49.45 14.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 120.89 1.06 . . . . 0.0 112.184 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.15 -50.1 47.31 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.981 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.694 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.4 t -66.13 -27.2 67.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 0.0 110.553 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.6 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.2 m . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 54.1 m . . . . . 0 N--CA 1.439 -0.976 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 52.6 Cg_exo -25.14 170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.667 2.911 . . . . 0.0 113.118 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 m -53.67 122.99 10.99 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.628 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.57 72.74 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.229 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.3 t -73.88 157.78 35.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.769 1.284 . . . . 0.0 111.536 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.513 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 20.1 m -70.96 132.33 45.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.777 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.94 93.17 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.888 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.15 -8.26 22.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.855 0.36 . . . . 0.0 110.581 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 56.8 m -82.01 -13.1 57.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 25.4 t80 -78.89 145.46 66.13 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.674 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -88.99 7.63 67.91 Favored 'Cis proline' 0 C--N 1.356 0.972 0 CA-C-N 120.041 1.05 . . . . 0.0 112.858 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 42.2 tt0 -64.33 -43.38 94.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 111.098 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 84.2 m 47.39 40.92 0.78 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 39.7 Cg_exo -58.05 150.97 61.4 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.293 1.329 . . . . 0.0 110.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.4 -56.67 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 120.941 1.094 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -27.83 69.41 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.674 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 5.9 t -66.32 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.184 0.516 . . . . 0.0 109.895 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.508 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 71.0 m . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.737 ' O ' ' O ' ' A' ' 9' ' ' PRO . 62.1 m . . . . . 0 N--CA 1.438 -1.074 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.737 ' O ' ' O ' ' A' ' 8' ' ' CYS . 17.3 Cg_exo -28.45 170.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.286 2.657 . . . . 0.0 112.812 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.3 m -53.46 124.86 16.04 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.63 72.78 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.272 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -73.89 159.46 32.78 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.145 1.472 . . . . 0.0 111.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.721 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 71.6 m -71.32 123.61 22.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.525 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.97 -46.32 55.61 Favored Glycine 0 N--CA 1.461 0.357 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.294 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.23 -8.05 28.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.652 0.263 . . . . 0.0 110.856 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.721 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 64.4 m -82.22 -3.4 55.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 13.5 t80 -80.74 146.24 59.84 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.62 10.42 61.69 Favored 'Cis proline' 0 C--N 1.351 0.66 0 CA-C-N 120.806 1.324 . . . . 0.0 112.419 -0.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.641 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 tp10 -63.78 -45.42 89.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 86.9 m 43.73 43.98 1.28 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 90.0 Cg_endo -78.04 154.34 29.28 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.027 1.818 . . . . 0.0 110.347 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.73 -52.71 5.59 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.064 1.176 . . . . 0.0 112.802 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.03 -43.6 72.67 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.044 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.79 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.58 -26.47 67.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 66.9 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.778 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.7 m . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.778 ' O ' ' O ' ' A' ' 8' ' ' CYS . 22.6 Cg_exo -26.2 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.762 2.975 . . . . 0.0 112.561 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.0 m -53.54 125.25 17.41 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.3 11.23 71.08 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 118.962 -1.589 . . . . 0.0 114.319 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 12.3 t -74.39 159.41 32.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.926 1.363 . . . . 0.0 111.404 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.722 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.7 m -71.61 118.56 14.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.549 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -47.67 -46.86 24.38 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.97 -8.66 39.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.673 0.273 . . . . 0.0 110.858 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -82.91 -1.8 53.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 14.0 t80 -80.95 147.04 60.67 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.862 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 12.5 Cg_endo -90.68 13.38 53.6 Favored 'Cis proline' 0 C--N 1.351 0.693 0 CA-C-N 120.517 1.22 . . . . 0.0 112.191 -1.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 18.2 tt0 -63.89 -47.01 82.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 109.881 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 75.9 m 44.07 44.42 1.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 73.6 Cg_endo -75.42 152.58 39.0 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 109.035 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.75 -49.94 13.13 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.854 1.036 . . . . 0.0 112.5 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.07 -46.25 78.72 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.482 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.772 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.2 t -66.37 -25.96 67.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 85.7 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' O ' ' O ' ' A' ' 9' ' ' PRO . 55.2 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.78 ' O ' ' O ' ' A' ' 8' ' ' CYS . 32.4 Cg_exo -25.55 170.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.873 3.048 . . . . 0.0 112.899 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.48 123.1 11.14 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.6 11.65 72.92 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.265 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.15 159.15 32.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.108 1.454 . . . . 0.0 111.481 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.727 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 53.2 m -71.12 121.92 19.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.183 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.91 -47.04 40.46 Favored Glycine 0 N--CA 1.461 0.348 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.57 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -8.11 27.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 72.3 m -81.98 -2.23 50.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 15.2 t80 -80.6 146.58 61.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.59 10.65 61.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 120.537 1.227 . . . . 0.0 112.328 -0.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.726 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 28.2 tt0 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.048 0.451 . . . . 0.0 110.025 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 76.3 m 45.47 43.58 1.39 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 91.4 Cg_endo -75.94 153.66 37.6 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.29 1.993 . . . . 0.0 110.078 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 1.1 Cg_endo -57.6 -52.62 5.87 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.908 1.072 . . . . 0.0 112.536 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.66 -45.54 60.02 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.77 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.776 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.6 t -66.51 -29.19 69.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 109.833 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.9 m . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.065 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.18 155.04 17.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 110.808 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -138.08 146.66 43.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.625 ' O ' ' HE2' ' A' ' 17' ' ' TYR . 2.0 pp -142.07 -38.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.071 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 149.07 49.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 111.449 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.558 ' N ' ' CE2' ' A' ' 17' ' ' TYR . . . 174.83 -172.62 45.62 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.45 139.95 35.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.884 0.85 . . . . 0.0 111.656 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.794 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.6 m -81.86 162.18 58.38 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.475 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.794 ' O ' ' O ' ' A' ' 8' ' ' CYS . 26.4 Cg_exo -24.06 171.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.045 3.164 . . . . 0.0 113.138 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.9 m -53.42 123.54 12.3 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 28' ' ' VAL . . . 71.27 10.98 70.62 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.353 -1.403 . . . . 0.0 114.142 175.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.55 157.33 35.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.541 1.17 . . . . 0.0 110.769 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.68 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 2.1 t -71.79 141.67 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.384 0.611 . . . . 0.0 110.855 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -45.66 93.79 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.082 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.19 -8.89 42.73 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.44 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 87.7 m -82.07 -5.96 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' HE2' ' O ' ' A' ' 4' ' ' ILE . 13.4 t80 -80.44 145.99 60.56 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.633 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.48 10.67 61.11 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.702 1.286 . . . . 0.0 112.364 -0.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 5.5 tt0 -63.81 -45.7 88.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.219 0.533 . . . . 0.0 109.994 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 74.3 m 43.87 44.43 1.46 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 95.2 Cg_endo -77.08 153.06 31.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.215 1.943 . . . . 0.0 109.887 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.56 -51.95 7.25 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 120.918 1.079 . . . . 0.0 112.565 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.61 -48.52 49.43 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.563 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.682 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 t -66.33 -27.61 68.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 110.417 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.0 m -74.79 -43.34 55.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.344 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.92 -34.64 11.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.736 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -113.88 139.93 48.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.742 0.306 . . . . 0.0 111.026 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 11' ' ' GLY . 14.2 t -145.33 118.4 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.0 94.82 1.03 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.884 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pp -67.44 -13.27 61.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.499 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.38 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.38 160.43 39.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.739 0.304 . . . . 0.0 110.548 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.4 144.58 49.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.451 HD12 ' C ' ' A' ' 4' ' ' ILE . 2.7 pp -139.28 151.71 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -131.65 -179.98 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 17' ' ' TYR . . . 176.3 -174.64 47.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.126 -1.035 . . . . 0.0 115.604 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 141.02 32.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.934 0.873 . . . . 0.0 111.291 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.3 m -82.11 162.12 57.96 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.486 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.775 ' O ' ' O ' ' A' ' 8' ' ' CYS . 31.2 Cg_exo -24.99 170.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.142 3.228 . . . . 0.0 112.959 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -53.7 123.31 11.91 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.522 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 11.35 71.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 118.952 -1.594 . . . . 0.0 114.15 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.4 t -73.89 157.16 36.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.628 1.214 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.799 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.7 m -71.86 118.58 14.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.43 -45.06 16.57 Favored Glycine 0 N--CA 1.46 0.271 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.405 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.19 -8.36 38.11 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.799 0.333 . . . . 0.0 110.863 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.2 m -83.09 -1.65 53.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CE2' ' N ' ' A' ' 6' ' ' GLY . 14.7 t80 -80.26 146.54 62.61 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -90.33 11.6 58.32 Favored 'Cis proline' 0 C--N 1.352 0.712 0 CA-C-N 120.665 1.273 . . . . 0.0 112.421 -0.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.688 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.4 tt0 -63.84 -45.48 89.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 109.983 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.7 m 43.36 42.86 0.88 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 96.2 Cg_endo -80.46 152.13 20.23 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.336 2.024 . . . . 0.0 110.305 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 -50.61 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 120.882 1.055 . . . . 0.0 112.172 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.65 -53.54 16.71 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.386 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.572 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.29 -26.39 67.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.31 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.629 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 61.9 m -75.06 -41.87 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.897 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -41.43 -70.8 0.39 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.545 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER 51.55 116.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 27' ' ' GLN . 53.8 t 63.68 132.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.085 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -150.66 131.42 14.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 30' ' ' LEU . 3.4 mm? -109.54 67.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.6 p30 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.836 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.06 154.34 17.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.651 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 147.6 47.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.036 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 5' ' ' THR . 2.4 pp -113.68 -41.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.548 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -93.44 114.47 26.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.485 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.528 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 175.56 176.21 43.62 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.325 -0.94 . . . . 0.0 114.924 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.4 140.23 34.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.868 0.842 . . . . 0.0 111.441 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.7 m -82.22 161.99 58.1 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.948 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 47.7 Cg_exo -24.04 170.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.188 3.259 . . . . 0.0 113.032 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -53.68 123.02 11.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 11.34 71.72 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.078 -1.534 . . . . 0.0 114.094 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -74.16 157.7 35.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.804 1.302 . . . . 0.0 111.224 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.778 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.0 m -71.98 119.63 16.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.735 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.14 -45.6 15.22 Favored Glycine 0 N--CA 1.461 0.322 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.286 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.31 -8.44 39.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 68.9 m -83.14 -4.39 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.528 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 18.9 t80 -80.34 146.44 62.03 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -89.81 10.48 61.43 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.537 1.228 . . . . 0.0 112.5 -0.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.7 tt0 -63.81 -45.87 87.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 73.1 m 43.82 42.54 0.88 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 96.5 Cg_endo -75.45 153.59 39.82 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.672 1.581 . . . . 0.0 109.977 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.59 -51.15 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 120.863 1.042 . . . . 0.0 112.132 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.42 -49.4 51.83 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.029 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.5 t -66.27 -27.64 68.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.191 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.4 m -74.73 -42.52 58.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.447 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -41.06 -29.63 0.33 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.575 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HG2' ' OG ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 54.42 158.69 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 111.697 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.26 120.35 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -56.7 94.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.954 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 tp -96.79 -74.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.985 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.931 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -138.3 146.41 42.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 111.07 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -144.84 148.56 34.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.942 HD12 HG22 ' A' ' 5' ' ' THR . 1.6 pp -126.28 -43.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.196 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.942 HG22 HD12 ' A' ' 4' ' ' ILE . 5.0 t -173.19 -177.91 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.261 . . . . 0.0 110.91 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 17' ' ' TYR . . . -160.87 52.06 0.34 Allowed Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 119.232 -1.461 . . . . 0.0 114.857 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 132.27 27.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.248 -0.976 . . . . 0.0 110.256 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.772 ' O ' ' O ' ' A' ' 9' ' ' PRO . 24.1 m -81.93 162.19 58.17 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.219 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.772 ' O ' ' O ' ' A' ' 8' ' ' CYS . 48.6 Cg_exo -24.75 170.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 124.078 3.185 . . . . 0.0 112.975 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 m -53.67 123.83 13.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.333 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.29 70.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.291 -1.433 . . . . 0.0 114.124 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.671 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -73.91 159.55 32.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.886 1.343 . . . . 0.0 111.985 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 1.3 t -71.8 137.12 47.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.263 176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 -48.27 82.36 Favored Glycine 0 CA--C 1.502 -0.78 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.664 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.54 -9.4 42.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.346 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 88.7 m -82.0 -1.59 48.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.0 t80 -80.42 146.48 61.73 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.9 Cg_endo -90.08 12.21 56.78 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 120.65 1.268 . . . . 0.0 112.304 -0.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 3.2 tt0 -63.41 -46.02 88.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 72.3 m 43.89 43.27 1.06 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 89.2 Cg_endo -77.15 152.52 31.21 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.022 1.815 . . . . 0.0 110.217 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.01 -50.56 11.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 121.09 1.193 . . . . 0.0 112.501 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.55 -49.07 58.84 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.886 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.705 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.27 -27.12 67.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.887 0.375 . . . . 0.0 110.35 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 90.0 m -74.17 -44.79 52.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.774 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.36 -44.43 95.18 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.58 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 28' ' ' VAL . 8.5 pt20 40.38 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.039 0.447 . . . . 0.0 112.146 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 27' ' ' GLN . 2.5 p 40.67 114.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.77 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -119.57 137.36 53.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.6 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -20.76 65.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 t -159.44 158.99 33.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.1 148.44 45.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.723 HD12 ' HB ' ' A' ' 5' ' ' THR . 2.6 pp -75.56 -41.35 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.547 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.723 ' HB ' HD12 ' A' ' 4' ' ' ILE . 13.1 t -133.34 163.73 28.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.311 0.577 . . . . 0.0 111.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.538 ' N ' ' CE1' ' A' ' 17' ' ' TYR . . . 173.01 -167.41 40.21 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.66 139.1 35.82 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.959 0.885 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.802 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.2 m -81.78 162.07 58.96 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.754 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.802 ' O ' ' O ' ' A' ' 8' ' ' CYS . 51.1 Cg_exo -22.43 170.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.286 3.324 . . . . 0.0 113.162 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -53.75 122.61 10.28 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 11.36 71.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 118.805 -1.664 . . . . 0.0 114.055 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.0 t -74.07 155.89 38.03 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.61 1.205 . . . . 0.0 110.628 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.784 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 36.5 m -71.94 124.42 24.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.883 0.373 . . . . 0.0 110.969 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.93 -45.92 41.05 Favored Glycine 0 N--CA 1.461 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -67.76 -8.1 32.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.729 0.3 . . . . 0.0 110.868 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 88.5 m -82.4 -1.89 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CE1' ' HA ' ' A' ' 5' ' ' THR . 11.3 t80 -80.22 146.27 62.16 Favored Pre-proline 0 N--CA 1.449 -0.507 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.31 11.06 60.2 Favored 'Cis proline' 0 C--N 1.354 0.824 0 CA-C-N 120.675 1.277 . . . . 0.0 112.096 -0.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.731 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 9.4 tt0 -63.8 -45.71 88.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.073 0.463 . . . . 0.0 110.12 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.1 m 43.5 45.58 1.91 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 98.0 Cg_endo -79.92 151.49 21.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.538 2.159 . . . . 0.0 110.335 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.06 -52.76 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.976 1.117 . . . . 0.0 112.405 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.29 -50.78 22.46 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.902 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.727 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.56 -28.18 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.008 0.433 . . . . 0.0 110.444 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 63.9 m -74.85 -40.9 60.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.934 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -41.25 -23.96 0.1 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.659 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -66.17 107.76 2.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.986 0.393 . . . . 0.0 111.43 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 t -145.88 118.48 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.389 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.8 119.53 31.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.539 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.03 51.7 0.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 111.206 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.913 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -176.6 164.14 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 110.962 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 59.84 151.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.712 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.2 pp -114.32 152.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.993 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.621 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 3.4 t -112.15 -177.39 3.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.54 0.685 . . . . 0.0 112.031 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' N ' ' CZ ' ' A' ' 17' ' ' TYR . . . 73.02 -5.47 18.37 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 115.931 1.132 . . . . 0.0 115.931 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.72 130.28 29.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.335 1.064 . . . . 0.0 112.599 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' ' O ' ' A' ' 9' ' ' PRO . 30.1 m -82.51 162.82 54.68 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.2 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.745 ' O ' ' O ' ' A' ' 8' ' ' CYS . 16.5 Cg_exo -26.62 170.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.112 3.208 . . . . 0.0 112.692 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 m -53.43 124.36 14.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.34 11.83 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.44 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.641 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 15.8 t -74.13 159.69 32.25 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 119.131 1.465 . . . . 0.0 111.79 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.737 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.5 m -71.65 119.34 15.67 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.198 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.82 -46.83 31.56 Favored Glycine 0 N--CA 1.463 0.44 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.73 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.69 -8.72 37.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 110.726 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -83.05 -1.95 54.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 5' ' ' THR . 16.1 t80 -80.69 147.74 63.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.218 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 13.1 Cg_endo -90.92 14.3 50.97 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 120.396 1.177 . . . . 0.0 112.073 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.698 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 1.5 tt0 -63.72 -47.06 82.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.012 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 78.9 m 45.32 42.65 1.05 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' CG ' ' A' ' 19' ' ' GLU . 97.2 Cg_endo -75.78 151.47 36.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.714 1.609 . . . . 0.0 109.096 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -49.45 14.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 120.89 1.06 . . . . 0.0 112.184 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.15 -50.1 47.31 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.981 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.694 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.4 t -66.13 -27.2 67.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 0.0 110.553 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.6 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.2 m -74.62 -44.32 51.12 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.16 -44.75 90.46 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.853 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -80.42 137.75 36.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.473 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.5 116.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.681 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.29 116.09 15.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 62.62 1.64 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.939 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -171.65 120.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.611 0.243 . . . . 0.0 110.811 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.36 153.75 5.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.126 0.489 . . . . 0.0 111.897 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' THR . 2.6 pp -144.9 -31.68 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.152 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' ILE . 6.8 t 50.47 160.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.049 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.728 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 72.58 144.04 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.081 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 144.82 36.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.958 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 54.1 m -81.8 161.81 59.78 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.728 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 52.6 Cg_exo -25.14 170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.667 2.911 . . . . 0.0 113.118 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 m -53.67 122.99 10.99 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.628 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.57 72.74 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.229 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.3 t -73.88 157.78 35.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.769 1.284 . . . . 0.0 111.536 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.513 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 20.1 m -70.96 132.33 45.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.777 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.94 93.17 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.888 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.15 -8.26 22.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.855 0.36 . . . . 0.0 110.581 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 56.8 m -82.01 -13.1 57.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.728 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 25.4 t80 -78.89 145.46 66.13 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.674 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -88.99 7.63 67.91 Favored 'Cis proline' 0 C--N 1.356 0.972 0 CA-C-N 120.041 1.05 . . . . 0.0 112.858 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 42.2 tt0 -64.33 -43.38 94.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 111.098 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 84.2 m 47.39 40.92 0.78 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 39.7 Cg_exo -58.05 150.97 61.4 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.293 1.329 . . . . 0.0 110.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.4 -56.67 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 120.941 1.094 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -27.83 69.41 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.674 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 5.9 t -66.32 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.184 0.516 . . . . 0.0 109.895 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.508 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 71.0 m -74.6 -43.74 54.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.78 -55.02 8.71 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.482 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 27' ' ' GLN . 1.1 pt20 -87.66 140.03 29.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.49 113.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.645 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 31' ' ' ASN . 5.4 t-20 -127.23 73.54 1.44 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.564 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pp -75.48 25.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 29' ' ' ASN . 3.8 m-80 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.727 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.922 -0.071 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 72.4 m -151.28 94.9 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.994 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 2' ' ' SER . 13.1 mt-30 -151.71 147.96 27.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.2 pp -80.4 140.46 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.477 ' O ' HD12 ' A' ' 4' ' ' ILE . 12.1 t -62.07 160.85 11.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.682 0.753 . . . . 0.0 111.291 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.632 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 71.08 136.1 0.14 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.833 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 142.57 35.01 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 109.643 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.737 ' O ' ' O ' ' A' ' 9' ' ' PRO . 62.1 m -81.69 161.77 60.22 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.522 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.737 ' O ' ' O ' ' A' ' 8' ' ' CYS . 17.3 Cg_exo -28.45 170.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.286 2.657 . . . . 0.0 112.812 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.3 m -53.46 124.86 16.04 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.63 72.78 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.272 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -73.89 159.46 32.78 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.145 1.472 . . . . 0.0 111.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.721 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 71.6 m -71.32 123.61 22.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.525 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.97 -46.32 55.61 Favored Glycine 0 N--CA 1.461 0.357 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.294 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.23 -8.05 28.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.652 0.263 . . . . 0.0 110.856 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.721 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 64.4 m -82.22 -3.4 55.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 13.5 t80 -80.74 146.24 59.84 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.62 10.42 61.69 Favored 'Cis proline' 0 C--N 1.351 0.66 0 CA-C-N 120.806 1.324 . . . . 0.0 112.419 -0.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.641 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 tp10 -63.78 -45.42 89.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 86.9 m 43.73 43.98 1.28 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 90.0 Cg_endo -78.04 154.34 29.28 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.027 1.818 . . . . 0.0 110.347 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.73 -52.71 5.59 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.064 1.176 . . . . 0.0 112.802 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.03 -43.6 72.67 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.044 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.79 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.58 -26.47 67.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 66.9 m -74.39 -43.71 55.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.95 -64.06 4.27 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.753 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 41.18 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -170.49 131.02 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.274 0.559 . . . . 0.0 111.361 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -72.58 144.38 47.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.012 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 0.77 26.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.004 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.741 -179.544 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -137.98 95.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.04 154.85 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.505 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.579 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.6 pp -62.89 150.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.84 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.511 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 3.4 t -100.47 -176.96 3.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.373 0.606 . . . . 0.0 111.566 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.49 ' N ' ' CZ ' ' A' ' 17' ' ' TYR . . . 72.1 -2.4 27.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.31 130.2 28.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.189 0.995 . . . . 0.0 112.874 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.778 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.7 m -82.58 162.13 56.77 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.765 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.778 ' O ' ' O ' ' A' ' 8' ' ' CYS . 22.6 Cg_exo -26.2 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.762 2.975 . . . . 0.0 112.561 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.0 m -53.54 125.25 17.41 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.3 11.23 71.08 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 118.962 -1.589 . . . . 0.0 114.319 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 12.3 t -74.39 159.41 32.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.926 1.363 . . . . 0.0 111.404 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.722 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.7 m -71.61 118.56 14.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.549 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -47.67 -46.86 24.38 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.97 -8.66 39.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.673 0.273 . . . . 0.0 110.858 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -82.91 -1.8 53.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' OH ' ' HA ' ' A' ' 5' ' ' THR . 14.0 t80 -80.95 147.04 60.67 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.862 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 12.5 Cg_endo -90.68 13.38 53.6 Favored 'Cis proline' 0 C--N 1.351 0.693 0 CA-C-N 120.517 1.22 . . . . 0.0 112.191 -1.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 18.2 tt0 -63.89 -47.01 82.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 109.881 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 75.9 m 44.07 44.42 1.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 73.6 Cg_endo -75.42 152.58 39.0 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 109.035 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.75 -49.94 13.13 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.854 1.036 . . . . 0.0 112.5 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.07 -46.25 78.72 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.482 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.772 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.2 t -66.37 -25.96 67.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 85.7 m -74.63 -44.88 48.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -87.28 -46.66 4.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.75 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 13.7 pt20 43.2 72.24 0.19 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.169 0.509 . . . . 0.0 111.903 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 26' ' ' GLY . 11.4 t -154.8 120.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.605 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.52 100.86 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.993 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tt -91.76 -66.77 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.181 -179.49 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.625 -0.19 . . . . 0.0 112.625 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.23 115.43 23.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.495 0.188 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 60.37 150.95 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.096 HD12 HG22 ' A' ' 5' ' ' THR . 1.6 pp -121.15 -49.13 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.502 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 1.096 HG22 HD12 ' A' ' 4' ' ' ILE . 6.8 t -165.94 -175.51 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.624 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 74.05 146.6 1.07 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 114.809 0.684 . . . . 0.0 114.809 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.79 142.63 34.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' O ' ' O ' ' A' ' 9' ' ' PRO . 55.2 m -81.91 161.91 59.17 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.668 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.78 ' O ' ' O ' ' A' ' 8' ' ' CYS . 32.4 Cg_exo -25.55 170.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.873 3.048 . . . . 0.0 112.899 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.48 123.1 11.14 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.6 11.65 72.92 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.265 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.15 159.15 32.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.108 1.454 . . . . 0.0 111.481 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.727 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 53.2 m -71.12 121.92 19.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.183 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.91 -47.04 40.46 Favored Glycine 0 N--CA 1.461 0.348 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.57 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -8.11 27.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 72.3 m -81.98 -2.23 50.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 15.2 t80 -80.6 146.58 61.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.59 10.65 61.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 120.537 1.227 . . . . 0.0 112.328 -0.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.726 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 28.2 tt0 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.048 0.451 . . . . 0.0 110.025 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 76.3 m 45.47 43.58 1.39 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 91.4 Cg_endo -75.94 153.66 37.6 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.29 1.993 . . . . 0.0 110.078 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 1.1 Cg_endo -57.6 -52.62 5.87 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.908 1.072 . . . . 0.0 112.536 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.66 -45.54 60.02 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.77 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.776 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.6 t -66.51 -29.19 69.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 109.833 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.9 m -75.11 -43.42 52.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.065 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.45 -53.7 5.84 Favored Glycine 0 CA--C 1.517 0.186 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.036 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.7 pp0? 38.03 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.944 0.402 . . . . 0.0 111.903 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 27' ' ' GLN . 91.5 t 66.1 124.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.316 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.4 143.72 32.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.315 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -63.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.07 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.065 -179.765 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.794 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.6 m . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 119.364 -0.351 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.794 ' O ' ' O ' ' A' ' 8' ' ' CYS . 26.4 Cg_exo -24.06 171.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.045 3.164 . . . . 0.0 113.138 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.9 m -53.42 123.54 12.3 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.27 10.98 70.62 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.353 -1.403 . . . . 0.0 114.142 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.55 157.33 35.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.541 1.17 . . . . 0.0 110.769 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.68 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 2.1 t -71.79 141.67 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.384 0.611 . . . . 0.0 110.855 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -45.66 93.79 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.082 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.19 -8.89 42.73 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.44 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 87.7 m -82.07 -5.96 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 13.4 t80 -80.44 145.99 60.56 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.633 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.48 10.67 61.11 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.702 1.286 . . . . 0.0 112.364 -0.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 5.5 tt0 -63.81 -45.7 88.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.219 0.533 . . . . 0.0 109.994 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 74.3 m 43.87 44.43 1.46 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 95.2 Cg_endo -77.08 153.06 31.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.215 1.943 . . . . 0.0 109.887 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.56 -51.95 7.25 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 120.918 1.079 . . . . 0.0 112.565 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.61 -48.52 49.43 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.563 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.682 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 t -66.33 -27.61 68.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 110.417 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.0 m . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.775 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.3 m . . . . . 0 N--CA 1.441 -0.905 0 CA-C-O 119.518 -0.277 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.775 ' O ' ' O ' ' A' ' 8' ' ' CYS . 31.2 Cg_exo -24.99 170.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.142 3.228 . . . . 0.0 112.959 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -53.7 123.31 11.91 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.522 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 11.35 71.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 118.952 -1.594 . . . . 0.0 114.15 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.64 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.4 t -73.89 157.16 36.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.628 1.214 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.799 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.7 m -71.86 118.58 14.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.43 -45.06 16.57 Favored Glycine 0 N--CA 1.46 0.271 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.405 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.19 -8.36 38.11 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.799 0.333 . . . . 0.0 110.863 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.2 m -83.09 -1.65 53.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.433 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 14.7 t80 -80.26 146.54 62.61 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -90.33 11.6 58.32 Favored 'Cis proline' 0 C--N 1.352 0.712 0 CA-C-N 120.665 1.273 . . . . 0.0 112.421 -0.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.688 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.4 tt0 -63.84 -45.48 89.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 109.983 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.7 m 43.36 42.86 0.88 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 96.2 Cg_endo -80.46 152.13 20.23 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.336 2.024 . . . . 0.0 110.305 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 -50.61 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 120.882 1.055 . . . . 0.0 112.172 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.65 -53.54 16.71 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.386 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.572 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.29 -26.39 67.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.31 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.629 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 61.9 m . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.897 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.7 m . . . . . 0 N--CA 1.445 -0.71 0 CA-C-O 119.566 -0.254 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 47.7 Cg_exo -24.04 170.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.188 3.259 . . . . 0.0 113.032 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -53.68 123.02 11.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 11.34 71.72 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.078 -1.534 . . . . 0.0 114.094 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.652 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -74.16 157.7 35.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.804 1.302 . . . . 0.0 111.224 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.778 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.0 m -71.98 119.63 16.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.735 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.14 -45.6 15.22 Favored Glycine 0 N--CA 1.461 0.322 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.286 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.31 -8.44 39.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 68.9 m -83.14 -4.39 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 18.9 t80 -80.34 146.44 62.03 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -89.81 10.48 61.43 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.537 1.228 . . . . 0.0 112.5 -0.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.7 tt0 -63.81 -45.87 87.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 73.1 m 43.82 42.54 0.88 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 96.5 Cg_endo -75.45 153.59 39.82 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.672 1.581 . . . . 0.0 109.977 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.59 -51.15 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 120.863 1.042 . . . . 0.0 112.132 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.42 -49.4 51.83 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.029 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.5 t -66.27 -27.64 68.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.191 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.4 m . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.447 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.772 ' O ' ' O ' ' A' ' 9' ' ' PRO . 24.1 m . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.772 ' O ' ' O ' ' A' ' 8' ' ' CYS . 48.6 Cg_exo -24.75 170.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 124.078 3.185 . . . . 0.0 112.975 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 m -53.67 123.83 13.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.333 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.29 70.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.291 -1.433 . . . . 0.0 114.124 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.671 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -73.91 159.55 32.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.886 1.343 . . . . 0.0 111.985 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 1.3 t -71.8 137.12 47.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.263 176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 -48.27 82.36 Favored Glycine 0 CA--C 1.502 -0.78 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.664 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.54 -9.4 42.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.346 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 88.7 m -82.0 -1.59 48.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.0 t80 -80.42 146.48 61.73 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.9 Cg_endo -90.08 12.21 56.78 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 120.65 1.268 . . . . 0.0 112.304 -0.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 3.2 tt0 -63.41 -46.02 88.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 72.3 m 43.89 43.27 1.06 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 89.2 Cg_endo -77.15 152.52 31.21 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.022 1.815 . . . . 0.0 110.217 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.01 -50.56 11.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 121.09 1.193 . . . . 0.0 112.501 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.55 -49.07 58.84 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.886 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.705 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.27 -27.12 67.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.887 0.375 . . . . 0.0 110.35 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 90.0 m . . . . . 0 N--CA 1.453 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.774 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.802 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.2 m . . . . . 0 N--CA 1.442 -0.847 0 CA-C-O 119.43 -0.319 . . . . 0.0 110.754 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.802 ' O ' ' O ' ' A' ' 8' ' ' CYS . 51.1 Cg_exo -22.43 170.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.286 3.324 . . . . 0.0 113.162 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -53.75 122.61 10.28 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 11.36 71.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 118.805 -1.664 . . . . 0.0 114.055 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.0 t -74.07 155.89 38.03 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.61 1.205 . . . . 0.0 110.628 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.784 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 36.5 m -71.94 124.42 24.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.883 0.373 . . . . 0.0 110.969 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.93 -45.92 41.05 Favored Glycine 0 N--CA 1.461 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -67.76 -8.1 32.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.729 0.3 . . . . 0.0 110.868 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 88.5 m -82.4 -1.89 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 11.3 t80 -80.22 146.27 62.16 Favored Pre-proline 0 N--CA 1.449 -0.507 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.31 11.06 60.2 Favored 'Cis proline' 0 C--N 1.354 0.824 0 CA-C-N 120.675 1.277 . . . . 0.0 112.096 -0.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.731 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 9.4 tt0 -63.8 -45.71 88.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.073 0.463 . . . . 0.0 110.12 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.1 m 43.5 45.58 1.91 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 98.0 Cg_endo -79.92 151.49 21.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.538 2.159 . . . . 0.0 110.335 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.06 -52.76 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.976 1.117 . . . . 0.0 112.405 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.29 -50.78 22.46 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.902 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.727 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.56 -28.18 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.008 0.433 . . . . 0.0 110.444 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 63.9 m . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.934 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' ' O ' ' A' ' 9' ' ' PRO . 30.1 m . . . . . 0 N--CA 1.446 -0.667 0 CA-C-O 119.406 -0.33 . . . . 0.0 111.2 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.745 ' O ' ' O ' ' A' ' 8' ' ' CYS . 16.5 Cg_exo -26.62 170.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.112 3.208 . . . . 0.0 112.692 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 m -53.43 124.36 14.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.34 11.83 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.44 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.641 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 15.8 t -74.13 159.69 32.25 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 119.131 1.465 . . . . 0.0 111.79 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.737 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.5 m -71.65 119.34 15.67 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.198 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.82 -46.83 31.56 Favored Glycine 0 N--CA 1.463 0.44 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.73 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.69 -8.72 37.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 110.726 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -83.05 -1.95 54.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 t80 -80.69 147.74 63.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.218 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 13.1 Cg_endo -90.92 14.3 50.97 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 120.396 1.177 . . . . 0.0 112.073 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.698 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 1.5 tt0 -63.72 -47.06 82.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.012 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 78.9 m 45.32 42.65 1.05 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' CG ' ' A' ' 19' ' ' GLU . 97.2 Cg_endo -75.78 151.47 36.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.714 1.609 . . . . 0.0 109.096 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -49.45 14.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 120.89 1.06 . . . . 0.0 112.184 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.15 -50.1 47.31 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.981 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.694 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.4 t -66.13 -27.2 67.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 0.0 110.553 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.6 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.2 m . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 54.1 m . . . . . 0 N--CA 1.439 -0.976 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 52.6 Cg_exo -25.14 170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.667 2.911 . . . . 0.0 113.118 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 m -53.67 122.99 10.99 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.628 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.57 72.74 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.229 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.3 t -73.88 157.78 35.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.769 1.284 . . . . 0.0 111.536 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.513 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 20.1 m -70.96 132.33 45.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.777 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.94 93.17 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.888 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.15 -8.26 22.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.855 0.36 . . . . 0.0 110.581 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 56.8 m -82.01 -13.1 57.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 25.4 t80 -78.89 145.46 66.13 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.674 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -88.99 7.63 67.91 Favored 'Cis proline' 0 C--N 1.356 0.972 0 CA-C-N 120.041 1.05 . . . . 0.0 112.858 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 42.2 tt0 -64.33 -43.38 94.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 111.098 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.575 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 84.2 m 47.39 40.92 0.78 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 39.7 Cg_exo -58.05 150.97 61.4 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.293 1.329 . . . . 0.0 110.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.4 -56.67 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 120.941 1.094 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -27.83 69.41 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.674 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 5.9 t -66.32 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.184 0.516 . . . . 0.0 109.895 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.508 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 71.0 m . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.737 ' O ' ' O ' ' A' ' 9' ' ' PRO . 62.1 m . . . . . 0 N--CA 1.438 -1.074 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.737 ' O ' ' O ' ' A' ' 8' ' ' CYS . 17.3 Cg_exo -28.45 170.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.286 2.657 . . . . 0.0 112.812 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.3 m -53.46 124.86 16.04 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.63 72.78 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.272 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -73.89 159.46 32.78 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.145 1.472 . . . . 0.0 111.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.721 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 71.6 m -71.32 123.61 22.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.525 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.97 -46.32 55.61 Favored Glycine 0 N--CA 1.461 0.357 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.294 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.23 -8.05 28.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.652 0.263 . . . . 0.0 110.856 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.721 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 64.4 m -82.22 -3.4 55.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 13.5 t80 -80.74 146.24 59.84 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.62 10.42 61.69 Favored 'Cis proline' 0 C--N 1.351 0.66 0 CA-C-N 120.806 1.324 . . . . 0.0 112.419 -0.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.641 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 tp10 -63.78 -45.42 89.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 86.9 m 43.73 43.98 1.28 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 90.0 Cg_endo -78.04 154.34 29.28 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.027 1.818 . . . . 0.0 110.347 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.73 -52.71 5.59 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.064 1.176 . . . . 0.0 112.802 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.03 -43.6 72.67 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.044 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.79 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.58 -26.47 67.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 66.9 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.778 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.7 m . . . . . 0 N--CA 1.447 -0.584 0 CA-C-O 119.291 -0.385 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.778 ' O ' ' O ' ' A' ' 8' ' ' CYS . 22.6 Cg_exo -26.2 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.762 2.975 . . . . 0.0 112.561 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.0 m -53.54 125.25 17.41 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.3 11.23 71.08 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 118.962 -1.589 . . . . 0.0 114.319 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 12.3 t -74.39 159.41 32.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.926 1.363 . . . . 0.0 111.404 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.722 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.7 m -71.61 118.56 14.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.549 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -47.67 -46.86 24.38 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.97 -8.66 39.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.673 0.273 . . . . 0.0 110.858 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -82.91 -1.8 53.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 14.0 t80 -80.95 147.04 60.67 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.862 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 12.5 Cg_endo -90.68 13.38 53.6 Favored 'Cis proline' 0 C--N 1.351 0.693 0 CA-C-N 120.517 1.22 . . . . 0.0 112.191 -1.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 18.2 tt0 -63.89 -47.01 82.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 109.881 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 75.9 m 44.07 44.42 1.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 73.6 Cg_endo -75.42 152.58 39.0 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 109.035 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.75 -49.94 13.13 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.854 1.036 . . . . 0.0 112.5 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.07 -46.25 78.72 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.482 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.772 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.2 t -66.37 -25.96 67.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 85.7 m . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.78 ' O ' ' O ' ' A' ' 9' ' ' PRO . 55.2 m . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 119.465 -0.302 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.78 ' O ' ' O ' ' A' ' 8' ' ' CYS . 32.4 Cg_exo -25.55 170.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.873 3.048 . . . . 0.0 112.899 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.48 123.1 11.14 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.6 11.65 72.92 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.265 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.15 159.15 32.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.108 1.454 . . . . 0.0 111.481 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.727 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 53.2 m -71.12 121.92 19.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.183 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.91 -47.04 40.46 Favored Glycine 0 N--CA 1.461 0.348 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.57 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -8.11 27.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 72.3 m -81.98 -2.23 50.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 15.2 t80 -80.6 146.58 61.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.59 10.65 61.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 120.537 1.227 . . . . 0.0 112.328 -0.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.726 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 28.2 tt0 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.048 0.451 . . . . 0.0 110.025 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 76.3 m 45.47 43.58 1.39 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 91.4 Cg_endo -75.94 153.66 37.6 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.29 1.993 . . . . 0.0 110.078 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 1.1 Cg_endo -57.6 -52.62 5.87 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.908 1.072 . . . . 0.0 112.536 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.66 -45.54 60.02 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.77 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.776 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.6 t -66.51 -29.19 69.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 109.833 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.9 m . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.065 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.672 -0.171 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.18 155.04 17.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 110.808 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -138.08 146.66 43.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.74 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.625 ' O ' ' HE2' ' A' ' 17' ' ' TYR . 2.0 pp -142.07 -38.71 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.071 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.57 149.07 49.62 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 111.449 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.558 ' N ' ' CE2' ' A' ' 17' ' ' TYR . . . 174.83 -172.62 45.62 Favored Glycine 0 N--CA 1.451 -0.308 0 N-CA-C 115.336 0.894 . . . . 0.0 115.336 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.45 139.95 35.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.884 0.85 . . . . 0.0 111.656 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.794 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.6 m -81.86 162.18 58.38 Favored Pre-proline 0 C--N 1.312 -1.024 0 CA-C-N 114.04 -1.436 . . . . 0.0 110.475 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.794 ' O ' ' O ' ' A' ' 8' ' ' CYS . 26.4 Cg_exo -24.06 171.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 124.045 3.164 . . . . 0.0 113.138 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.9 m -53.42 123.54 12.3 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.479 -0.489 . . . . 0.0 110.803 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 28' ' ' VAL . . . 71.27 10.98 70.62 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 119.353 -1.403 . . . . 0.0 114.142 175.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.55 157.33 35.65 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 118.541 1.17 . . . . 0.0 110.769 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.68 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 2.1 t -71.79 141.67 49.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.384 0.611 . . . . 0.0 110.855 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.77 -45.66 93.79 Favored Glycine 0 C--N 1.316 -0.551 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.082 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -68.19 -8.89 42.73 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.471 -0.364 . . . . 0.0 110.44 -178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 87.7 m -82.07 -5.96 58.79 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.625 ' HE2' ' O ' ' A' ' 4' ' ' ILE . 13.4 t80 -80.44 145.99 60.56 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.633 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.48 10.67 61.11 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.702 1.286 . . . . 0.0 112.364 -0.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 5.5 tt0 -63.81 -45.7 88.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.219 0.533 . . . . 0.0 109.994 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 74.3 m 43.87 44.43 1.46 Allowed Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' ' CB ' ' A' ' 24' ' ' CYS . 95.2 Cg_endo -77.08 153.06 31.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.215 1.943 . . . . 0.0 109.887 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.56 -51.95 7.25 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 120.918 1.079 . . . . 0.0 112.565 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.61 -48.52 49.43 Favored Glycine 0 C--N 1.315 -0.636 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.563 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.682 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.9 t -66.33 -27.61 68.03 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 110.417 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.578 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.0 m -74.79 -43.34 55.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.344 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.92 -34.64 11.68 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.736 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -113.88 139.93 48.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.742 0.306 . . . . 0.0 111.026 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 11' ' ' GLY . 14.2 t -145.33 118.4 2.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.0 94.82 1.03 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.884 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pp -67.44 -13.27 61.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.499 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.406 -0.807 . . . . 0.0 111.38 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.38 160.43 39.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.739 0.304 . . . . 0.0 110.548 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.4 144.58 49.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.005 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.451 HD12 ' C ' ' A' ' 4' ' ' ILE . 2.7 pp -139.28 151.71 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.858 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.7 t -131.65 -179.98 5.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.495 ' N ' ' CE2' ' A' ' 17' ' ' TYR . . . 176.3 -174.64 47.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.126 -1.035 . . . . 0.0 115.604 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.45 141.02 32.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.934 0.873 . . . . 0.0 111.291 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.775 ' O ' ' O ' ' A' ' 9' ' ' PRO . 34.3 m -82.11 162.12 57.96 Favored Pre-proline 0 C--N 1.31 -1.133 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.486 178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.775 ' O ' ' O ' ' A' ' 8' ' ' CYS . 31.2 Cg_exo -24.99 170.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 124.142 3.228 . . . . 0.0 112.959 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.5 m -53.7 123.31 11.91 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.522 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.31 11.35 71.29 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 118.952 -1.594 . . . . 0.0 114.15 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.64 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.4 t -73.89 157.16 36.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 118.628 1.214 . . . . 0.0 111.155 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.799 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 63.7 m -71.86 118.58 14.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.893 177.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.43 -45.06 16.57 Favored Glycine 0 N--CA 1.46 0.271 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.405 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -68.19 -8.36 38.11 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.799 0.333 . . . . 0.0 110.863 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.2 m -83.09 -1.65 53.36 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CE2' ' N ' ' A' ' 6' ' ' GLY . 14.7 t80 -80.26 146.54 62.61 Favored Pre-proline 0 N--CA 1.449 -0.514 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -90.33 11.6 58.32 Favored 'Cis proline' 0 C--N 1.352 0.712 0 CA-C-N 120.665 1.273 . . . . 0.0 112.421 -0.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.688 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.4 tt0 -63.84 -45.48 89.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 109.983 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.7 m 43.36 42.86 0.88 Allowed Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.688 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 96.2 Cg_endo -80.46 152.13 20.23 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.336 2.024 . . . . 0.0 110.305 178.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -55.99 -50.61 11.78 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 120.882 1.055 . . . . 0.0 112.172 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.65 -53.54 16.71 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.386 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.572 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.29 -26.39 67.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.041 0.448 . . . . 0.0 110.31 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.629 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 61.9 m -75.06 -41.87 58.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.897 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -41.43 -70.8 0.39 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.977 -0.556 . . . . 0.0 113.545 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.46 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER 51.55 116.98 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.475 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 27' ' ' GLN . 53.8 t 63.68 132.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.085 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -150.66 131.42 14.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.712 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 30' ' ' LEU . 3.4 mm? -109.54 67.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.906 0.384 . . . . 0.0 111.171 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 38.6 p30 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.836 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.06 154.34 17.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.692 0.282 . . . . 0.0 110.651 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 147.6 47.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.036 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 5' ' ' THR . 2.4 pp -113.68 -41.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.548 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -93.44 114.47 26.88 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.485 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.528 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 175.56 176.21 43.62 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.325 -0.94 . . . . 0.0 114.924 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.4 140.23 34.94 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.868 0.842 . . . . 0.0 111.441 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 29.7 m -82.22 161.99 58.1 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.948 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 47.7 Cg_exo -24.04 170.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.188 3.259 . . . . 0.0 113.032 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.9 m -53.68 123.02 11.09 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.72 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.41 11.34 71.72 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.078 -1.534 . . . . 0.0 114.094 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.652 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -74.16 157.7 35.49 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.804 1.302 . . . . 0.0 111.224 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.778 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.0 m -71.98 119.63 16.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.735 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.14 -45.6 15.22 Favored Glycine 0 N--CA 1.461 0.322 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.286 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.31 -8.44 39.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.748 0.309 . . . . 0.0 110.788 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 68.9 m -83.14 -4.39 58.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.528 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 18.9 t80 -80.34 146.44 62.03 Favored Pre-proline 0 N--CA 1.445 -0.698 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 Cg_endo -89.81 10.48 61.43 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 120.537 1.228 . . . . 0.0 112.5 -0.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 34.7 tt0 -63.81 -45.87 87.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.093 0.473 . . . . 0.0 109.759 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.622 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 73.1 m 43.82 42.54 0.88 Allowed Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.664 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 96.5 Cg_endo -75.45 153.59 39.82 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.672 1.581 . . . . 0.0 109.977 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.59 -51.15 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 120.863 1.042 . . . . 0.0 112.132 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.42 -49.4 51.83 Favored Glycine 0 C--N 1.316 -0.574 0 CA-C-N 114.82 -1.082 . . . . 0.0 113.029 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.5 t -66.27 -27.64 68.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.941 0.401 . . . . 0.0 110.191 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.533 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 67.4 m -74.73 -42.52 58.13 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.447 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 27' ' ' GLN . . . -41.06 -29.63 0.33 Allowed Glycine 0 CA--C 1.52 0.38 0 CA-C-N 115.696 -0.683 . . . . 0.0 113.575 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HG2' ' OG ' ' A' ' 13' ' ' SER . 0.4 OUTLIER 54.42 158.69 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.988 0.423 . . . . 0.0 111.697 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.7 t -144.26 120.35 4.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.953 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -56.7 94.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.954 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 tp -96.79 -74.52 0.56 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.808 0.337 . . . . 0.0 110.985 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.931 -179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 t -138.3 146.41 42.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 111.07 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -144.84 148.56 34.14 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.9 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.942 HD12 HG22 ' A' ' 5' ' ' THR . 1.6 pp -126.28 -43.57 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.196 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.942 HG22 HD12 ' A' ' 4' ' ' ILE . 5.0 t -173.19 -177.91 1.64 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.647 0.261 . . . . 0.0 110.91 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 17' ' ' TYR . . . -160.87 52.06 0.34 Allowed Glycine 0 CA--C 1.505 -0.566 0 C-N-CA 119.232 -1.461 . . . . 0.0 114.857 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 132.27 27.9 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.248 -0.976 . . . . 0.0 110.256 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.772 ' O ' ' O ' ' A' ' 9' ' ' PRO . 24.1 m -81.93 162.19 58.17 Favored Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.219 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.772 ' O ' ' O ' ' A' ' 8' ' ' CYS . 48.6 Cg_exo -24.75 170.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 124.078 3.185 . . . . 0.0 112.975 178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.1 m -53.67 123.83 13.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.281 -0.568 . . . . 0.0 110.333 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.08 11.29 70.18 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.291 -1.433 . . . . 0.0 114.124 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.671 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 11.1 t -73.91 159.55 32.63 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 118.886 1.343 . . . . 0.0 111.985 -178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 16' ' ' CYS . 1.3 t -71.8 137.12 47.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.333 0.587 . . . . 0.0 110.263 176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 -48.27 82.36 Favored Glycine 0 CA--C 1.502 -0.78 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.664 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -67.54 -9.4 42.13 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.346 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 13' ' ' SER . 88.7 m -82.0 -1.59 48.72 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.0 t80 -80.42 146.48 61.73 Favored Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.406 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 10.9 Cg_endo -90.08 12.21 56.78 Favored 'Cis proline' 0 C--N 1.352 0.743 0 CA-C-N 120.65 1.268 . . . . 0.0 112.304 -0.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.624 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 3.2 tt0 -63.41 -46.02 88.29 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 72.3 m 43.89 43.27 1.06 Allowed Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.705 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 89.2 Cg_endo -77.15 152.52 31.21 Favored 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.022 1.815 . . . . 0.0 110.217 178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -56.01 -50.56 11.93 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 121.09 1.193 . . . . 0.0 112.501 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.55 -49.07 58.84 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.886 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.705 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.27 -27.12 67.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.887 0.375 . . . . 0.0 110.35 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.489 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 90.0 m -74.17 -44.79 52.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.774 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -58.36 -44.43 95.18 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.58 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.532 ' O ' ' O ' ' A' ' 28' ' ' VAL . 3.0 pt20 40.38 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.039 0.447 . . . . 0.0 112.146 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.532 ' O ' ' O ' ' A' ' 27' ' ' GLN . 2.5 p 40.67 114.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.77 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -119.57 137.36 53.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.6 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.88 -20.76 65.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.152 -0.927 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 t -159.44 158.99 33.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.985 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.1 148.44 45.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.723 HD12 ' HB ' ' A' ' 5' ' ' THR . 2.6 pp -75.56 -41.35 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.547 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.723 ' HB ' HD12 ' A' ' 4' ' ' ILE . 13.1 t -133.34 163.73 28.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.311 0.577 . . . . 0.0 111.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.538 ' N ' ' CE1' ' A' ' 17' ' ' TYR . . . 173.01 -167.41 40.21 Favored Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.66 139.1 35.82 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.959 0.885 . . . . 0.0 111.13 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.802 ' O ' ' O ' ' A' ' 9' ' ' PRO . 53.2 m -81.78 162.07 58.96 Favored Pre-proline 0 C--N 1.31 -1.145 0 CA-C-N 113.875 -1.511 . . . . 0.0 110.754 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.802 ' O ' ' O ' ' A' ' 8' ' ' CYS . 51.1 Cg_exo -22.43 170.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 124.286 3.324 . . . . 0.0 113.162 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.8 m -53.75 122.61 10.28 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.637 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.43 11.36 71.83 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 118.805 -1.664 . . . . 0.0 114.055 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.0 t -74.07 155.89 38.03 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 118.61 1.205 . . . . 0.0 110.628 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.784 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 36.5 m -71.94 124.42 24.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.883 0.373 . . . . 0.0 110.969 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.93 -45.92 41.05 Favored Glycine 0 N--CA 1.461 0.309 0 C-N-CA 121.063 -0.589 . . . . 0.0 113.41 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -67.76 -8.1 32.79 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.729 0.3 . . . . 0.0 110.868 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.784 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 88.5 m -82.4 -1.89 51.39 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.588 ' CE1' ' HA ' ' A' ' 5' ' ' THR . 11.3 t80 -80.22 146.27 62.16 Favored Pre-proline 0 N--CA 1.449 -0.507 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.31 11.06 60.2 Favored 'Cis proline' 0 C--N 1.354 0.824 0 CA-C-N 120.675 1.277 . . . . 0.0 112.096 -0.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.731 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 9.4 tt0 -63.8 -45.71 88.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.073 0.463 . . . . 0.0 110.12 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.556 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 87.1 m 43.5 45.58 1.91 Allowed Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.731 ' HD3' ' HG2' ' A' ' 19' ' ' GLU . 98.0 Cg_endo -79.92 151.49 21.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.538 2.159 . . . . 0.0 110.335 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -57.06 -52.76 5.99 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 120.976 1.117 . . . . 0.0 112.405 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.29 -50.78 22.46 Favored Glycine 0 C--N 1.314 -0.684 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.902 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.727 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.1 t -66.56 -28.18 68.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.008 0.433 . . . . 0.0 110.444 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.577 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 63.9 m -74.85 -40.9 60.75 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.934 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -41.25 -23.96 0.1 Allowed Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.659 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' HA ' ' NE2' ' A' ' 27' ' ' GLN . 6.2 mm-40 -66.17 107.76 2.05 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.986 0.393 . . . . 0.0 111.43 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.7 t -145.88 118.48 2.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.389 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.8 119.53 31.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.539 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.6 tp -103.03 51.7 0.79 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.757 0.313 . . . . 0.0 111.206 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.913 179.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -176.6 164.14 2.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 110.962 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 59.84 151.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.712 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.2 pp -114.32 152.44 15.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.993 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.621 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 3.4 t -112.15 -177.39 3.15 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.54 0.685 . . . . 0.0 112.031 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.494 ' N ' ' CZ ' ' A' ' 17' ' ' TYR . . . 73.02 -5.47 18.37 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 115.931 1.132 . . . . 0.0 115.931 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.72 130.28 29.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 122.335 1.064 . . . . 0.0 112.599 178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' ' O ' ' A' ' 9' ' ' PRO . 30.1 m -82.51 162.82 54.68 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.2 178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.745 ' O ' ' O ' ' A' ' 8' ' ' CYS . 16.5 Cg_exo -26.62 170.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.112 3.208 . . . . 0.0 112.692 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 m -53.43 124.36 14.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.727 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.34 11.83 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.072 -1.537 . . . . 0.0 114.44 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.641 ' HB3' ' CB ' ' A' ' 8' ' ' CYS . 15.8 t -74.13 159.69 32.25 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 119.131 1.465 . . . . 0.0 111.79 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.737 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 68.5 m -71.65 119.34 15.67 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.198 177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.82 -46.83 31.56 Favored Glycine 0 N--CA 1.463 0.44 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.73 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.69 -8.72 37.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 110.726 -177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -83.05 -1.95 54.05 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 5' ' ' THR . 16.1 t80 -80.69 147.74 63.64 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.218 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 13.1 Cg_endo -90.92 14.3 50.97 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 120.396 1.177 . . . . 0.0 112.073 -1.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.698 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 1.5 tt0 -63.72 -47.06 82.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.104 0.478 . . . . 0.0 110.012 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.58 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 78.9 m 45.32 42.65 1.05 Allowed Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.698 ' HD3' ' CG ' ' A' ' 19' ' ' GLU . 97.2 Cg_endo -75.78 151.47 36.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.714 1.609 . . . . 0.0 109.096 177.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -49.45 14.98 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 120.89 1.06 . . . . 0.0 112.184 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.15 -50.1 47.31 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.981 -179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.694 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.4 t -66.13 -27.2 67.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.84 0.352 . . . . 0.0 110.553 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.6 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.2 m -74.62 -44.32 51.12 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.914 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.16 -44.75 90.46 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.853 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 mm-40 -80.42 137.75 36.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.473 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -147.5 116.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.681 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -133.29 116.09 15.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.393 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 62.62 1.64 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.125 0.488 . . . . 0.0 110.833 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.939 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.236 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.9 p -171.65 120.89 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.611 0.243 . . . . 0.0 110.811 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.36 153.75 5.17 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.126 0.489 . . . . 0.0 111.897 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' THR . 2.6 pp -144.9 -31.68 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.152 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' ILE . 6.8 t 50.47 160.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.049 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.728 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 72.58 144.04 0.52 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.081 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.18 144.82 36.82 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.346 0.593 . . . . 0.0 109.958 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.785 ' O ' ' O ' ' A' ' 9' ' ' PRO . 54.1 m -81.8 161.81 59.78 Favored Pre-proline 0 C--N 1.309 -1.184 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.728 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.785 ' O ' ' O ' ' A' ' 8' ' ' CYS . 52.6 Cg_exo -25.14 170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.667 2.911 . . . . 0.0 113.118 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 m -53.67 122.99 10.99 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.628 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.57 72.74 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.083 -1.532 . . . . 0.0 114.229 175.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.3 t -73.88 157.78 35.69 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 118.769 1.284 . . . . 0.0 111.536 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.513 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 20.1 m -70.96 132.33 45.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.777 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.94 93.17 Favored Glycine 0 CA--C 1.509 -0.3 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.888 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -66.15 -8.26 22.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.855 0.36 . . . . 0.0 110.581 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.513 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 56.8 m -82.01 -13.1 57.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.728 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 25.4 t80 -78.89 145.46 66.13 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.674 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.508 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -88.99 7.63 67.91 Favored 'Cis proline' 0 C--N 1.356 0.972 0 CA-C-N 120.041 1.05 . . . . 0.0 112.858 0.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 21' ' ' PRO . 42.2 tt0 -64.33 -43.38 94.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.278 0.561 . . . . 0.0 111.098 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.575 ' N ' ' HD3' ' A' ' 21' ' ' PRO . 84.2 m 47.39 40.92 0.78 Allowed Pre-proline 0 C--N 1.326 -0.44 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.629 ' HG3' ' HG2' ' A' ' 19' ' ' GLU . 39.7 Cg_exo -58.05 150.97 61.4 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.293 1.329 . . . . 0.0 110.761 178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.4 -56.67 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 120.941 1.094 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -61.99 -27.83 69.41 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.674 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.553 ' HB2' ' HB2' ' A' ' 21' ' ' PRO . 5.9 t -66.32 -29.74 70.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.184 0.516 . . . . 0.0 109.895 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.508 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 71.0 m -74.6 -43.74 54.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.904 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.78 -55.02 8.71 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.482 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 27' ' ' GLN . 1.1 pt20 -87.66 140.03 29.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.057 0.456 . . . . 0.0 111.04 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.49 113.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.645 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 31' ' ' ASN . 5.4 t-20 -127.23 73.54 1.44 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.564 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pp -75.48 25.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 29' ' ' ASN . 3.8 m-80 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.727 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.922 -0.071 . . . . 0.0 112.922 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 72.4 m -151.28 94.9 2.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.994 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 2' ' ' SER . 13.1 mt-30 -151.71 147.96 27.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.823 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.554 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.2 pp -80.4 140.46 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.477 ' O ' HD12 ' A' ' 4' ' ' ILE . 12.1 t -62.07 160.85 11.83 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.682 0.753 . . . . 0.0 111.291 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.632 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 71.08 136.1 0.14 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.833 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.62 142.57 35.01 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.265 0.555 . . . . 0.0 109.643 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.737 ' O ' ' O ' ' A' ' 9' ' ' PRO . 62.1 m -81.69 161.77 60.22 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.522 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.737 ' O ' ' O ' ' A' ' 8' ' ' CYS . 17.3 Cg_exo -28.45 170.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.286 2.657 . . . . 0.0 112.812 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 67.3 m -53.46 124.86 16.04 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.983 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.58 11.63 72.78 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.272 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -73.89 159.46 32.78 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 119.145 1.472 . . . . 0.0 111.442 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.721 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 71.6 m -71.32 123.61 22.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.525 177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.97 -46.32 55.61 Favored Glycine 0 N--CA 1.461 0.357 0 C-N-CA 120.907 -0.663 . . . . 0.0 113.294 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -67.23 -8.05 28.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.652 0.263 . . . . 0.0 110.856 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.721 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 64.4 m -82.22 -3.4 55.01 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 13.5 t80 -80.74 146.24 59.84 Favored Pre-proline 0 N--CA 1.444 -0.734 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.6 Cg_endo -89.62 10.42 61.69 Favored 'Cis proline' 0 C--N 1.351 0.66 0 CA-C-N 120.806 1.324 . . . . 0.0 112.419 -0.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.641 ' CG ' ' HD3' ' A' ' 21' ' ' PRO . 5.2 tp10 -63.78 -45.42 89.83 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 0.0 110.216 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.468 ' N ' ' CD ' ' A' ' 21' ' ' PRO . 86.9 m 43.73 43.98 1.28 Allowed Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.79 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 90.0 Cg_endo -78.04 154.34 29.28 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.027 1.818 . . . . 0.0 110.347 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -57.73 -52.71 5.59 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.064 1.176 . . . . 0.0 112.802 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.03 -43.6 72.67 Favored Glycine 0 C--N 1.314 -0.668 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.044 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.79 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 5.4 t -66.58 -26.47 67.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.792 0.329 . . . . 0.0 110.72 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 66.9 m -74.39 -43.71 55.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.863 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.95 -64.06 4.27 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.753 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 41.18 95.28 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -170.49 131.02 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.274 0.559 . . . . 0.0 111.361 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.58 144.38 47.91 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.012 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.04 0.77 26.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.004 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.741 -179.544 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -137.98 95.77 3.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.04 154.85 9.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.505 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.579 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.6 pp -62.89 150.6 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.84 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.511 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 3.4 t -100.47 -176.96 3.36 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.373 0.606 . . . . 0.0 111.566 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.49 ' N ' ' CZ ' ' A' ' 17' ' ' TYR . . . 72.1 -2.4 27.29 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.31 130.2 28.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.189 0.995 . . . . 0.0 112.874 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.778 ' O ' ' O ' ' A' ' 9' ' ' PRO . 37.7 m -82.58 162.13 56.77 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 113.392 -1.731 . . . . 0.0 110.765 178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.778 ' O ' ' O ' ' A' ' 8' ' ' CYS . 22.6 Cg_exo -26.2 170.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 123.762 2.975 . . . . 0.0 112.561 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.0 m -53.54 125.25 17.41 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.614 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.3 11.23 71.08 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 118.962 -1.589 . . . . 0.0 114.319 175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 12.3 t -74.39 159.41 32.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 118.926 1.363 . . . . 0.0 111.404 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.722 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 74.7 m -71.61 118.56 14.59 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.549 177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -47.67 -46.86 24.38 Favored Glycine 0 N--CA 1.461 0.332 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.659 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.97 -8.66 39.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 120.673 0.273 . . . . 0.0 110.858 -177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.722 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 69.5 m -82.91 -1.8 53.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' OH ' ' HA ' ' A' ' 5' ' ' THR . 14.0 t80 -80.95 147.04 60.67 Favored Pre-proline 0 N--CA 1.445 -0.722 0 CA-C-N 115.987 -0.552 . . . . 0.0 109.862 178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 12.5 Cg_endo -90.68 13.38 53.6 Favored 'Cis proline' 0 C--N 1.351 0.693 0 CA-C-N 120.517 1.22 . . . . 0.0 112.191 -1.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.701 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 18.2 tt0 -63.89 -47.01 82.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.098 0.475 . . . . 0.0 109.881 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.517 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 75.9 m 44.07 44.42 1.5 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 73.6 Cg_endo -75.42 152.58 39.0 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 121.959 1.773 . . . . 0.0 109.035 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -56.75 -49.94 13.13 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 120.854 1.036 . . . . 0.0 112.5 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.07 -46.25 78.72 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.822 -1.081 . . . . 0.0 113.482 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.772 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.2 t -66.37 -25.96 67.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 0.0 110.782 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 85.7 m -74.63 -44.88 48.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.854 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -87.28 -46.66 4.92 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.75 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.437 ' O ' ' HG3' ' A' ' 27' ' ' GLN . 13.7 pt20 43.2 72.24 0.19 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.169 0.509 . . . . 0.0 111.903 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 26' ' ' GLY . 11.4 t -154.8 120.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.605 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.52 100.86 5.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.993 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 tt -91.76 -66.77 0.9 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.752 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.273 -0.87 . . . . 0.0 111.181 -179.49 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.625 -0.19 . . . . 0.0 112.625 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.23 115.43 23.77 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.495 0.188 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 60.37 150.95 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 121.007 0.432 . . . . 0.0 110.625 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.096 HD12 HG22 ' A' ' 5' ' ' THR . 1.6 pp -121.15 -49.13 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.502 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 1.096 HG22 HD12 ' A' ' 4' ' ' ILE . 6.8 t -165.94 -175.51 3.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.624 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.577 ' HA3' ' CZ ' ' A' ' 17' ' ' TYR . . . 74.05 146.6 1.07 Allowed Glycine 0 CA--C 1.523 0.545 0 N-CA-C 114.809 0.684 . . . . 0.0 114.809 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.79 142.63 34.67 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.78 ' O ' ' O ' ' A' ' 9' ' ' PRO . 55.2 m -81.91 161.91 59.17 Favored Pre-proline 0 C--N 1.308 -1.227 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.668 179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.78 ' O ' ' O ' ' A' ' 8' ' ' CYS . 32.4 Cg_exo -25.55 170.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.873 3.048 . . . . 0.0 112.899 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.48 123.1 11.14 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.504 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.6 11.65 72.92 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 118.773 -1.68 . . . . 0.0 114.265 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 11.9 t -74.15 159.15 32.96 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 119.108 1.454 . . . . 0.0 111.481 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.727 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 53.2 m -71.12 121.92 19.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.183 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.91 -47.04 40.46 Favored Glycine 0 N--CA 1.461 0.348 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.57 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -8.11 27.74 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.746 0.308 . . . . 0.0 110.757 -177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 13' ' ' SER . 72.3 m -81.98 -2.23 50.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.577 ' CZ ' ' HA3' ' A' ' 6' ' ' GLY . 15.2 t80 -80.6 146.58 61.16 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 17' ' ' TYR . 9.4 Cg_endo -89.59 10.65 61.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 120.537 1.227 . . . . 0.0 112.328 -0.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.726 ' HG2' ' HD3' ' A' ' 21' ' ' PRO . 28.2 tt0 -64.02 -47.35 80.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.048 0.451 . . . . 0.0 110.025 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 76.3 m 45.47 43.58 1.39 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HG2' ' HB2' ' A' ' 24' ' ' CYS . 91.4 Cg_endo -75.94 153.66 37.6 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.29 1.993 . . . . 0.0 110.078 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 1.1 Cg_endo -57.6 -52.62 5.87 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 120.908 1.072 . . . . 0.0 112.536 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.66 -45.54 60.02 Favored Glycine 0 C--N 1.317 -0.512 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.77 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.776 ' HB2' ' HG2' ' A' ' 21' ' ' PRO . 4.6 t -66.51 -29.19 69.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.079 0.466 . . . . 0.0 109.833 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG2' ' A' ' 9' ' ' PRO . 68.9 m -75.11 -43.42 52.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.065 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.664 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.45 -53.7 5.84 Favored Glycine 0 CA--C 1.517 0.186 0 CA-C-N 115.401 -0.818 . . . . 0.0 114.036 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.664 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 1.7 pp0? 38.03 96.31 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.944 0.402 . . . . 0.0 111.903 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 27' ' ' GLN . 91.5 t 66.1 124.84 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.316 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.4 143.72 32.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.315 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -63.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.07 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.065 -179.765 . . . . . . . . 0 0 . 1 stop_ save_